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The

oxidative

behavior

of

Auranofin,

glucopyranosato-S(triethylphosphine)gold(I),

was

2,3,4,6-tetra-O-acetyl- 1-thio-P-Dinvestigated

by

using

cyclic

~ ~ 0.1 M Bu4NPFdCH2C12 solutions
voltammetry (CV) in 0.1 M B U & G ~ F & H ~ Cand
using Pt working and auxiliary electrodes and a Ag/AgCl reference. CV studies at scan
rates from 50-2,000 mVs" and Auranofin concentrations between 1 and 4 mM, show two
irreversible oxidation processes occurring at + 1.1 V and +1.6 V vs. Ag/AgCl.
Treatment of Auranofrn with the one electron oxidizing agent [Cp2Fe]PF6 gave a
p-thiolato

digold

cluster,

[(Et3PAu)2(p-SR)]?

and

the

disulfide,

bis(tetraacetlythiog1ucose). A mechanism for Auranofin oxidation is proposed on the

basis of chemical and electrochemical studies. The p-thiolato species is also obtained by
treatment of Auranofin with Et3PAuN03 in CH3CN or addition of methanolic silver
nitrate to an equimolar mixture of Auranofin and Et3PAuC1 followed by product

isolation.

The

X-ray

structure

is

reported

for

the

Auranofin

analogue,

[A1~(PMe~)~(thioglucose)2](NO3)2.
The structure of the cluster confirms the coordination

of two Me3PAu' to a bridging thiolato moiety and the two-thiolates are on opposite sides
and trans to each other. The gold-gold distances are Aul-Au2= 3.106(7), Aul-AuA=
3.17 1( 1l), and Au2-Au2A= 3.144( 12)8,.
The cyclic voltammetry of Solganol, aurothioglucose, was investigated in 0.5 M
NaC104/H20 solutions using a three-electrode system consisting of a platinum working
electrode, a platinum-wire auxiliary electrode, and a silver-silver chloride reference
electrode. A broad peak obtained at +1.2 V, which affected by scan rate and pH changes.
Multiple CV scans of Solganol showed an enhancement in current due to a possible
filming on the electrode surface. Bulk electrolysis of Solganol showed n

=

2. Chemical

oxidation using [CpzFeIPFs showed no change in the NIvR peaks and there was no
change in the color of the mixture. Based on bulk electrolysis, resistance to chemical
oxidation, and pH studies, the peak at +1.2 V vs Ag/AgCl was assigned as AuVnl.
A series of binuclear Au(1) halide and thiolate complexes (AuX)2dppbz (X
Br, I, p-SC&CH3)

=

C1,

were synthesized. All of the newly synthesized complexes gave

satisfactory elemental analysis and characterized by 'H and 31PNMR. The complex
(AuCl)2dppbz crystallized in the orthorhombic space group Pbca with a
b

=

18.160(2), c

=

22.225(1)

A, a = p = y =90°, Z = 8 (at 293 K).

length of 2.99 8, is in the range of gold-gold interaction distance.

=

16.955(3),

The Au ...Au bond

11
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CHAPTER 1

Introduction

Oxidation States of Gold

Gold can be found in several oxidation states; 0, I, and I11 are the most common
but complexes containing gold in the -I, 11, IV,V states are known.’,2 Gold coordination
chemistry is dominated by the oxidation states I and 111. Gold(I), with the electron
configuration of [Xe]4f45d”, usually forms linear compounds with sp hybridization at
gold; however trigonal planar (sp2 hybridization) and tetrahedral (sp3 hybridization)
coordination geometries are known. The first example of a tetrahedral gold(1) center
characterized by X-ray crystallography, is the bis chelated diphosphine complex
[Au(dppe)2I2’, where dppe is 1,Zbis(diphentlphosphno)ethane.’
Gold(1) is a soft metal ion and therefore has a preference for soft donor atoms,
such as sulfur, over hard ligands such as nitrogen and oxygen. Compounds of gold(III),
with electron configuration of [Xe]4f4$, i.e. isoelectronic with platinum(II), are square
planar with four donor atoms. Gold(1II) is a hard metal ion and favors hard donor atoms
such as nitrogen and oxygen more than gold(I).’”

In the absence of stabilizing ligands gold(1) disproportionates to gold(0) and
gold(III), a powerful oxidizing agent. It is this property which precludes the use of
gold(II1) as a useful pharmaceutical in the reducing mammalian environment. Ligands

2

that stabilize gold(1) include cyanide, phosphines, arsines and a range of sulfurcontaining ligands (sulfides and thiols for example).’”

History of Gold in Medicine

Gold is an ancient metal with a long medical history. The biological benefits
attributed to gold in history may surpass its monetary attraction. Gold has been used in a

In medieval Europe alchemists
variety of forms as a medicine by ancient civili~ations.~’~
had a variety of prescriptions known as aurum potabile, which contained small amounts
of gold. In the 17‘hcentury, a gold cordial was used for the treatment of ailments, such as
fever which was believed to be caused by a decrease in the vital spirit. A mixture of gold
chloride and sodium chloride, Na[AuC14] was used in the 19* century to treat syphilis.
Gold cyanide, K[Au(CN)z], discovered by the German bacteriologist Robert Koch in the
twentieth century, was used as a bacteriostatic toward the tubercle bacillus. Gold therapy
for tuberculosis was subsequently introduced in the 1920s. The suggestion that the
tubercle bacillus was the causative agent for rheumatoid arthritis led to the use of gold
therapy for this disease, which led the Empire Rheumatism Council in 1960 to confirm
the effectiveness of gold compounds against rheumatoid a r t h r i t i ~ . ~ , ~

Gold@)Drugs in the Treatment of Rheumatoid Arthritis, Cancer, and AIDS

Rheumatoid arthritis is a chronic inflammatory disease characterized by erosion
of peripheral joints. It is a systemic autoimmune disorder of unknown e t i ~ l o g y .The
~
early gold dmgs used for treatment of rheumatoid arthritis, for almost six decades, were

3

water-soluble gold(1) thiolate complexes such as Myochrysine and Solganol. These drugs
are administered by deep intramuscular injection at weekly intervals. They provide
considerable pain relief, decrease joint inflammation, and more importantly, restore joint
function. Improvement in the disease is not expected for at least four months after
beginning a course of

injection^.^ During treatment with Myochrysine, gold was found in

much higher concentrations in the red blood cells of smokers than in the same cells in
non-~rnokers.~
The reason is that hydrogen cyanide is inhaled by smokers and forms the
very stable complex, gold cyanide which allows the gold to be taken up and bound to red
cells. Serious side effects were noticed such as nephrotoxicity, mouth ulcers, skin
reactions, and blood disorders. The high toxicity and serious side effects led to the search
for a drug with reduced toxicity and higher pharmacological activity.
In 1985, Auranofin (Figure 1.1) was reported to be orally effective in human

rheumatoid arthritis

condition^.^ The advantages of oral Auranofin over injectable drugs

include lower gold levels in blood and kidney and less t ~ x i c i t y That
. ~ the anti-arthritic
action of Auranofin is due to gold is proven by the fact that the non-gold-containing
substructures of Auranofin administered to rats have no effect.3k The orally active
Auranofin drug is slightly less effective than the injectable drugs but causes fewer serious
side effects.
There is no unique mechanism of action for antiarthritic gold drugs due to the
lack of understanding of rheumatoid arthritis. From a practical point of view, the main
advantage of understanding the mechanism of action would be to improve the therapeutic
to toxic ratio of gold

drug^.',^,^

4

/OAC

I

OAc

Auranofin

/OH

n

Solganol

Myoc hrysine

Figure 1.1. Structure of gold(1) drugs used as anti-rheumatoid arthritis.

5

Gold compounds such as the tetrahedral complex [Au(dppe)2]Cl have also shown
promising medical activity as antitumor drugs. The proposed mechanism of action was
the formation of DNA-protein cross-links.’ Although this compound had remarkable
activity against cancer cells; it was not entered for clinical trials due to problems with
cardiotoxicity during toxicology ~ t u d i e s . ~
The demonstration of antitumor activity of [Au(dppe)2]C1 encouraged wider
studies

on

other

gold

complexes

(Figure

1.2).

[AuClz(damp)],

damp

=

dimethylaminomethylphenyl (Figure 1.2) has been evaluated for human tumor cells.Ib
Initial studies indicated that this new drug demonstrated modest antitumor activity, seen
as a reduction in tumor growth, against breast cancer. An evaluation of the antitumor
activity of Auranofin showed that it was active against some tumor models in vivo but
ineffective against solid tumors.lb
The design and testing of gold complexes for antitumor activity over the past
several decades has been based on three

rationale^^-^: (1) analogies between square planar

complexes of Pt(I1) and Au(III), both of which are d8 ions; (2) analogy to the
immunomodulatory effects of gold(1) antiarthritic agents; (3) complexation of gold(1) and
gold(II1) with known antitumor agents to form new compounds with enhanced activity.
The discovery that Auranofin had activity against HeLa cells in vitro and P388 leukemia
cells in vivo led to the screening of many Auranofin

analogue^.^

The retrovirus, which causes AIDS, is human immunodeficiency virus (“€I”’).

HIV is part of a group of slow viruses, which cause diseases that develop extremely
slowly. A powerful means to attack the AIDS virus would be to find a specific inhibitor

6

Au(damp)Xp (X = CI-,OAc-, etc.)
damp

= dimethylaminomethylphenyl

APPhp
PhpP
I
I

I
I

Au

Au

CI

CI

dppe

A
Ph2P\ Au./pph2
+
/
/

..

Ph2pWpPh

= bis(d ipheny I ph0sphino)ethane

Figure 1.2. Structure of gold(I) complexes used as anticancer.
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for the replication process of the HIV virus. Gold cyanide, [Au(CN)z]', is found at
varying levels in patients treated with common antiarthritic drugs. The observation that
infected cells incubated with gold cyanide showed rapid uptake of gold suggested the
possibility that gold cyanide might be useful in the treatment of AIDS." Gold cyanide
can readily enter cells and attack the replication process of the retrovirus in an infected
host. Interestingly, only 20 ppb of gold cyanide were required to inhibit the replication of

HIV in vitro."
The chemistry of gold is intriguing in its history, which is one of the most
interesting and colorful stories in chemistry. There is little wonder that gold easily
occupied an honored place when it was considered for therapeutic purposes.
Many questions remain to be answered in gold chemistry: How are gold drugs
distributed in the body's organs? How does gold produce its toxic effects? What effects
do gold drugs have on the immune system? The search for the answer for these questions
is challenging in studying gold drugs.

X-ray Structure of Gold@) Drugs

The X-ray crystallography of Auranofin shows a monomer with a near linear SAu-P linkage (173.6') and virtually identical S-Au (2.29

A)

and Au-P (2.26

A)

bond

lengths (Table 1.1 and Figure 1.3)." The glucopyranose ring is not planar but exists in
the chair conformation. The gold side chain is oriented markedly toward the ring oxygen
suggesting some type of attraction (Figure 1.3), perhaps Van der Waals nature, between
gold and oxygen atom.

8

After many decades of effort, the Myochrysine analogue [CsNa2HAu2(STm)2In ,
Figure 1.4, has been crystallized and its structure determined by X-ray crystallography.”
Using vapor phase deposition, Bau was able to isolate tiny colorless crystals in the form
of thin square tiles or, more commonly, stubby needles in about two weeks.I2 The
crystals were allowed to grow slowly over a 2 months period to a size adequate for X-ray
collection. The structure is polymeric with two interpenetrating spirals. Helices of
opposite
handiness occur in equal numbers: the right-handed helices contain exclusively Sthiomalate. The bridging Au-S bond distances are 2.28 and 2.26

A. Table 1.1 shows the

bond lengths (A) and angles (O) of Auranofin, Myochrysine, and related structures. l 2 - I 5

Table 1.1. Bond lengths (A) and Angles (O) of Auranofin, Myochrysine, and
related structures.

R = C~H~PI-‘~,
Tm = Thiomalate.

9

“7

07

I

?

Au

7

H18

05

Figure 1.3. X-ray structure of A~ranofin.’~
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Figure 1.4. X-ray structure of Myochrysine analogue.12
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Bioinorganic Pharmacology of Gold Drugs

A considerable body of evidence suggests that in vivo gold exists primarily as
g o ~ d ( ~3)~.1 4 ~ 1Gold
5
drugs exposed to body fluids and proteins react predominantly by
ligand exchange reactions that preserve the gold(1) oxidation

Aurosomes

(lysosomes that accumulate large amounts of gold and undergo morphological changes)
from gold-treated rats contain predominantly gold(I), even when gold(II1) has been
administered.

Thiols and thioethers, including cysteine and methionine residues in

proteins and peptides, are capable of reducing gold(II1) to gold(1) (Figure 1.5).16,'7Even
disulfide bonds react rapidly to reduce gold(I1I).I6 Thus, it appears that the bulk of gold
present in vivo is likely to be gold(1). Nonetheless, the potential for oxidizing gold@)to
gold(II1) in vivo has long been recognized."

myleoperoxidase/ oxidative burst

Golddrugs -+ Au(1) Metabolites

Gold (I11

thiols, thioethers, disulfides

Figure 1.5. Biological Redox Cycling of gold(1) and ~ o I ~ ( I I I ) . ~ , * ~

The high affinity of gold(1) for sulfur and selenium ligands suggests that proteins,
including enzymes and transport proteins, will be critical in vivo targets. In addition, it is
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clear that extracellular gold in the blood is primarily protein bound, suggesting proteinmediated transport of gold during
Serum albumin, the principal extracellular protein of blood, binds between 80%
and 95% of the gold in serum and functions as a defacto transport agent. Thirty-four of its
35 cysteine residues are present as 17 disulfide bonds. Auranofin reacts with the a cys-34

in albumin via a ligand exchange reaction that displaces the sulfhydryl groups (Figure
1.6) to form AlbSAuPEt3. The same product is obtained if Et3PAuC1 reacts with
a l b ~ m i n . ' ~ The
* ' ~ product
* ~ ~ showed 31PNMR peak at 38.8 ppm (Table 1.2).

Et3P

y
+

- CH2\

s-CH,

,,Albumin

HS-CH,,
Albumin

+

Et3P0

HS- CH2'

Figure 1.6. Reactions of serum albumin with Auranofin in buffered aqueous solutions at
pH values near physiological pH.19

The free acetylthioglucose liberated from Auranofin reacts further with the
cysteine-34 disulfide bonds to liberate cysteine and also displaces the Et3P ligand, leading
to its oxidation (Figure 1.6).20Under conditions approximating those in vivo, complex
formation is first-order in Auranofin and has a rate constant of 2.9 k 0.2 s-', which
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indicates that Auranofin will have a short lifetime after entering the bloodstream where
albumin is present in large excess.
Sadler and colleagues reported a conformational change in albumin that
accompanies gold binding to c y ~ - 3 4 . ~ ~The
, " rate of gold binding may correspond either
to the rate of opening of the cys-34 crevice to solvent molecules or to the rate of the
conformational change that accommodates gold binding.
Hemoglobin reacts with Et3PAu+ taken up by red cells exposed in vitro to
Et3PAuCI although it may not be a significant red cell binding site at the lower
concentrations that prevail during clinical use of Auranofin." 31P NMR evidence is
consistent with the formation of S-Au-P coordination by displacement of chloride at the
hemoglobin cysteine p93 residues, which are on the surface of the p subunits."

Table 1.2. 31PNMR of Gold -Protein Complexes.
Complex

31PNMR

Ref
23,24

24
Alb-S-(AuPEb);!

36.5

24

Hb-(SAuPEt3), 7

34.0

25

Previous studies have demonstrated that Auranofin can undergo facile thiolexchange reactions with biological ligands. In acidic medium, like the stomach, the
reactivity of the thiolate ligand of Auranofin can be enhanced.21 Auranofin reacts with
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HC1

in

aqueous

solution

and

in

50%

methanovwater

to

form

chloro(triethylphosphine)gold(I) and the product reacts with Auranofin to form a thiolatebridged dinuclear gold complex with two gold triethylphosphine moieties bound to a
single thioglucose ligand (Figure 1.7). The thermodynamics and kinetics of these
reactions have been studied in water and in 50% methanollwater. The equilibrium

M-' in water and 2.0 x

constants for the formation of Et3PAuC1 are 4.6 x

M-' in

50% methanol/water.26The equilibrium constant for the formation of the thiolate-bridged
digold complex is 1.2 x 1O3 (water), 1.3 x 1O2 (50% methanol/water), and 0.7 x 1O2 (95%
methanol). The kinetics for the formation of the thiolate-bridged digold complex is too
rapid to be observed by ordinary mixing techniques.

r

l+

L

J

Thiolate bridged digold complex

Figure 1.7. Reaction of Auranofin with HCl in water or 50% methanol/water.26
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Previous Redox Studies of Gold@)Drugs

Hypochlorus acid (HOCI), which is generated by the enzyme myeloperoxidase
during the oxidative burst at inflammed sites, can oxidize the gold in Myochrysine to
gold(II1) in ~ i t r o . ~ ’ ,This
~ ’ finding has been extended to additional gold compounds. For
example, gold(1) thiolates including Auranofin are oxidized to Au(I1I) with preliminary
or concomitant oxidation of the ligand~.~’

Et3PAuSAtg + 5 OC1- + 2H+
l/n[AuSR], + 4 OC1-

+ 2H’

+ AuCli + AtgS03- +Et3PO + H20 +C1+ AuC1i + RS03- + H20

1.1
1.2

The dc and differential pulse polarography studies of Auranofin by Perez and
coworkers at a dropping mercury electrode, establishes that Auranofin undergoes a
diffusion controlled and reversible reductive redox process at -0.5 V vs. SCE at pH
greater than 9.5.29 Bulk electrolysis at -0.8 V yields an n value of 1 indicative that
reduction involves the AuVocouple. Below a pH of about 8.5, a proton dependent
pathway occurs. Protonation of triethylphosphine

@Ka

=

8.69) is believed to be

responsible for the shift in potential as a function of pH. A linear relationship between the
limiting current and Auranofin concentration was also noted in the concentration range
3.63 x lo-’ to 5.1 x lom4M.29
The reducing properties of antiarthritic drugs such as Auranofin, Solganol, and
Myochrysine were investigated by Huck and

coworker^.^' The standard redox potentials

of drugs which instantly react with the oxidant, 5,5’-dithiobis-(2-nitrobenzoicacid), were
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determined by titration with potassium hexacyanoferrate(II1) in a 0.1 M phosphate buffer

@H 7.0, 25OC), at a dropping mercury electrode using a SCE reference. Unfortunately,
none of the gold-containing compounds reacted very quickly with the oxidant and the
standard potentials could not be measured directly even after long incubation periods in
phosphate buffer at 370C.30

Photophysical Studies of Gold@)Drugs
The study of the excited state of gold drugs could also lead to significant advances
in the understanding of the mechanism of Au(1) drugs in the body which are used for the
According to Corey and Khan, several gold drugs
treatment of rheumatoid arthriti~.~'
have been shown to quench singlet oxygen,

' 0 2

(Table 1.3). They propose that it is by

this action that gold compounds are capable of aiding in the treatment of the disease
which appears to be oxygen related.31
Emission from singlet oxygen occurs at 7752 cm-' .32 The molecule is converted to
its lower lying triplet state. The quenching of singlet oxygen is thought to occur by
energy transfer to species with electronic or vibrational states that are energetically
compatible or by the interaction of singlet oxygen with heavy atoms that have large spin
orbit coupling. The proposals for the action of gold drugs in the quenching mechanism of
1

0 2

have led our group and others to study the photophysical properties of gold(1)

c~rnplexes.~~'~~
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Auranofin is luminescent in the solid state and in EtOH glasses at 77K (Arna
618

=

Auranofin is also photoreactive (Amaw = 254 nm) in acetonitrile, undergoing

photodecomposition that appears not to include production of elemental gold.

Table 1.3. Rate constants for the quenching of

Quencher

I
lo7

'02

by various

I

agent^:^'

I

MethodB
0 . 2 lo7
~

Auranofin

0.75

Et3PAuSCH3

4.5 lo7

3.7

p-Carotene

1.1 x 10'O

1.5 x 10'"

lo7

dimethylnaphthalene- 1,4-endoperoxide at 3OoC. Method B: solvent, benzene;

'02

generated by self-sensitized photooxidation of rubrene at 30' C.

Electrochemistry Overview
Over the past couple of decades potential sweep techniques, such as cyclic
voltammetry, have been applied to an ever-interesting range of systems, and at the same
time the mathematical description of these techniques have been developed sufficiently to
enable kinetic parameters to be determined for a wide variety of

mechanism^.^^

Reversible Systems. A simple reversible reaction can be described by Equation 1.6 and

0 is the only species present in solution. As soon as a potential where 0 is reduced is
reached the surface concentration of 0 decreases Gom its bulk value in order to satisfy
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the Nernst equation and a concentration gradient is set up (Figure 1.8). The surface
concentration of 0 is further decreased until it effectively reaches zero. Reversible cyclic
voltammogram can only be observed if both 0 and R are stable and the kinetics of the
electron transfer process are fast.35

0

+ ne-

= R

1.6

Diagnostic tests for cyclic voltammograms of reversible processes are as follows:35

I . AE, = E,*

-E,C

= 59/11 mV

2. Ep-Ep,2= 59/n mV

3. I, A/IC,= 1

4. I,
5.

cc vlR ( v

is scan rate)

E, is independent of v

Irreversible Systems. The most marked feature of a cyclic voltammogram of a totally

irreversible system is the total absence of a reverse peak. Whereas for the reversible case

:
the value of E," is independent of the sweep rate, v, for the irreversible case E

is found

to vary with the sweep rate (Figure 1.9). It can be seen in Figure 1.9 that increasing the
scan rate increases the peak separation and the peak height is slightly reduced from that
for a reversible
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Diagnostic tests for cyclic voltammograms of an irreversible processes are as follows:35
1. No reverse peak
2. I," oc v " (~v is scan rate)
3. Ep-E,/2 = 48/acna mV
4.

E
:

shifts -30/acna mV for each decade increase in v

Quasi-reversible Systems. It is quite common for a process that is reversible at low

sweep rates to become irreversible at higher ones after having passed through a region
known as quasi-reversible at intermediate values (Figure 1.10). This transition from
reversibility occurs when the relative rate of the electron transfer with respect to that of
mass transport is insufficient to maintain Nernestian equilibrium at the electrode surface.

Diagnostic tests for cyclic voltammograms of quasi-reversible processes are as follows:35

1. AEp is greater than 59/11 mV and increase with increasing v
2. I, A/I, C

=

1 provided ccc = a~ = 0.5

3 . I, increases with v ' ' ~but not proportional to it
4.

E
:

shifts negatively with increasing v

As a general conclusion, the extent of irreversibility increases with increase in
sweep rate, while at the same time there is a decrease in the peak current relative to the
reversible case and an increasing separation between anodic and cathodic peaks.
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Figure 1.8. Cyclic voltammogram for a reversible process, 0 + e- = R. (a) v, (b) 1Ov,
(c) 50v, and (d) ~ O O V . ~ ~
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E - E:/V

I
a
I

c

0.2

0.1

0.0

-0.1

-

E-E:/V

-0.2

Figure 1.9. Cyclic voltammogram for an irreversible process, 0 + e- = R.

potential sweep rates (a) 0.13 Vs-', (b) 1.3 Vs-I, (c) 4 Vs-', (d) 13 VS-'.~'
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IIAt

/

Reversible

Figure 1.10. Transition fiom a reversible to an irreversible system on increasing scan
rate.35
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Goals of This Work

Little is known concerning the redox behavior of the anti-rheumatoid arthritis
gold thiolate drugs. Hoping to contribute to understanding the possible sources of toxic
and therapeutic causes of gold drugs, we conducted chemical and electrochemical redox
studies on Auranofin and Solganol. An understanding of the oxidative properties of gold
drugs is important in light of the proposed toxic side effects of Au(II1) in vivo. In a broad
sense, the goals of this thesis stem fiom the poor understanding of the fate of gold
thiolate drugs in the oxidizing biological environment.

Our group has been studying the electronic structure and thermal, electronic, and
photochemical reactivity of d'' gold(1) complexes, especially those containing phosphine
~ ~ . ~ ~ our group studied the chemical oxidation of gold
and thiolate l i g a n d ~ . Recently
thiolates using [Cp#e]PF6 in methylene chloride.36 Chemical titration experiments on
Ph3PAu(SC&CH3)

using the mild oxidant, [CpzFe]PF6 confirms the formation of

significant quantities of disulfide, (SC&CH3)2.

Chemical oxidation afforded the

opportunity to isolate the products of the first oxidation process. Reaction of 0.5 mmol of
Ph3PAu(SC6&CH3) and 0.25 mmol of [Cp#e]PF6 in CH2C12 resulted in formation of
[(Ph3P)4Au4(~-SC~CH3)2][PF6],(SC6&CH3)2, and C P ~ F Similar
~ . ~ ~oxidation studies
have been carried out on dinuclear gold thiolates. Disulfide and tetranuclear gold clusters
were i ~ o l a t e d . ~ ~ . ~ ~
My first project involved the electrochemical oxidation and bulk electrolysis
studies of Auranofin in 0.1 M Bu&F"F'&H2C12

and 0.1 M B Q N B F ~ / C H ~ Csolutions
I~
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using Pt working and auxiliary electrodes and a Ag/AgCl reference. Results are discussed
in chapter 2.

My next project involved treatment of Auranofin with the one electron oxidizing
agent, [Cp2Fe]PF6. The oxidation resulted in a p-thiolato digold cluster [Et3PAu)~(p-

SR)]22' and the disulfide, bis(tetraacetylthiog1ucose). The p-thiolato species was obtained
several by independent procedures involving the treatment of Auranofin with Et3PAuN03
in CH3CN or CH2C12 or addition of methanolic silver nitrate to an equimolar mixture of
Auranofin and Et3PAuCl. The cluster was characterized using 'H NMR,31PNMR,mass
spectroscopy, and elemental analysis. Disulfide exchange reactions of the tetragold
cluster with bis(tetraacetylthioglucose), (SC&C1)2,

(SC6&CH3)2, and glutathione

disulfide were studied. I tried growing x-ray quality crystals of the cluster by varying the
counter anion from PF; to NO3-, BFi, CF3S03-, Sn(Ph)z(N03)3-. The results of these
trials are presented in chapter 3. Successful trial to grow X-ray quality crystals was
acheived by changing the triethylphosphine group to trimethylphosphine. X-ray structure
of the tetragold(1) cluster is discussed in chapter 3.

The electrochemical and chemical oxidation of the polymeric gold(1) thiolate drug
Solganol will provide the literature with a broad understanding of the oxidative behavior
or the source of toxicity of monomeric (Auranofin) versus polymeric (Solganol) gold
drugs.

25

The last project involves the synthesis, characterization, and investigation of the
photophysical behavior of a new class of halo and thiolato gold(1) complexes of the
formula (AuX)zdppbz, X = C1, Br, I, p-SC6KCH3.

Hopefully my thesis will stimulate further studies in the biochemistry of gold
drugs.
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CHAPTER 2

Electrochemical Oxidation of Auranofin: An Anti-arthritic
Gold @)-SulfurDrug'

Introduction
The medicinal effects of gold drugs have been extensively investigated during the
last two decades.* However, a recent review of the electrochemical literature shows that
the redox data for biologically important gold and silver complexes is generally still
l a ~ k i n g .This
~
is especially significant for gold drugs, where the redox reactivity,
especially oxidation, has been invoked in partial explanation of both therapeutic and toxic
side effects.

Aura nofin

Auranofin, (2,3,4,6-tetra-O-acetyl- 1-thio-p-D-glucopyranosato-

S)(triethylphosphine)gold(I), is a water insoluble phosphine gold thiolate complex that is
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used as an orally active anti-arthritic drug in both experimental animals and man.
Reductive polarography of Auranofin has been previously r e p ~ r t e dAuranofin
.~
has been
investigated by a variety of

technique^.^^^,^ X-ray crystallography shows that Auranofin is

monomeric with a nearly linear S-Au-P linkage (173.6') and virtually identical Au-S
(2.29 A') and Au-P (2.26 A') bond

length^.^ The triethylphosphine group appears to

. ~ 1 9 7 AMossbauer
~
for Auranofin shows relatively
stabilize the gold-thiol m ~ i e t y The
high parameters (IS

=

3.55 mndsec, QS

=

8.64 mmhec, relative to gold) compared to

Myocrisin and Solganol, intrinsic to the Au-P bond.' Auranofin is luminescent in the
solid state and in EtOH glasses at 77K (Amax = 61 8

(Amm

=

Auranofin is also photoreactive

254 nm) in acetonitrile, undergoing photodecomposition that appears not to

include production of elemental gold.8 The dc and differential pulse polarography studies
of Auranofin by Perez and coworkers at a dropping mercury electrode, establishes that
Auranofin undergoes a diffusion controlled and reversible redox process at -0.5 V (vs.
SCE) at pH greater than 9.5.4 Bulk electrolysis at -0.8 V leads to an n value of 0.9

electrons per molecule and suggests that the reduction involves the AuI/O ~ o u p l e . ~
Oxidation of Auranofin with hypochlorite, a strong oxidant released by
phagocytic cells, has also been studied by Shaw and coworkers.' Sulfonate and Et,PO
formed first followed by oxidation of Au(1) to Au(II1).
The electrochemistry of a series of neutral phosphine gold(1) thiolate complexes
has been investigated in our laboratory.6 The series includes cyclic dinuclear gold(1)
complexes formed from 1,2-propanedithiolate (pdt) and bis-chelating phosphines,
Au,(LL)(pdt) (LL= dppe and dpppn), open dinuclear gold(1) complexes formed from
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para-thiocresolate (p-tc) and bis-chelating phosphines, Au~(LL)@-tc)2(LL= ddpe, dppp,
dppb, dpppn), and a mononuclear complex, Au(PPh3)@-tc). Oxidative cyclic
voltammetry experiments were performed at Pt and glassy carbon electrodes in 0.1 M
B Q N P F ~ C H ~ C Nand

CH2C12 solutions. Adsorption

effects

occurred

in

all

electrode/solvent combinations investigated and were minimized by wiping the electrode
between each CV experiment. The position and wave shape of the oxidation processes
were somewhat dependent on the electrode/solvent combination.
Our goal is to report oxidative cyclic voltammetry and bulk electrolysis studies of
Auranofin.

Experimental Section
Reagents. Methylene chloride and the supporting electrolytes, tetra-N-butylammonium

hexafluorophosphate

(BqNPF6)

and

tetra-N-butylammonium

tetrafluoroborate

(BmNBF4) were used as received (Aldrich). Auranofin was purchased from Pfanstiehl
Laboratories, Inc., IL. PPh3Au-p-tc was prepared according to previously published
methods5
Abbreviations. The following abbreviations are used: p-tc

= p-thiocresol,

pdt

= propane

dithiolate, dppe = bis(dipheny1phosphine) ethane, rev = reversible, irr = irreversible.
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Ft Button Worlung Electrode

Ag/AgCl Reference Electrode

Ft Paddle Coimter Electrode

Figure 2.1. Cell for cyclic voltammetry experiments.

Cyclic Voltammetry (CV) Experiments. CV experiments were conducted using an

EG&G Princeton Applied Research 273 potentiostat/galvanostat under computer control.
CV measurements were performed in methylene chloride with 0.1 M BQNPF, or 0.1
BQNBF~as supporting electrolyte. Fresh solutions containing electrolyte (1 0 ml) were
prepared prior to each CV experiment. Each solution was deoxygentaed by purging with
nitrogen for 2-5 minutes. Background CV’s were acquired before the addition of gold
complex. A three-electrode system was used, comprised of a platinum (1.6 mm diameter)
working electrode, a platinum wire or paddle auxiliary electrode, and a silvedsilver
chloride (Ag/AgCl) reference electrode (Figure 2.1). The working electrode was wiped
prior to each experiment. The auxiliary electrode was lightly sanded before each set of
experiments with fine sand paper. Potentials are reported vs. Ag/AgCl at room
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temperature and are not corrected for junction potentials. Each CV experiment was
repeated a number of times.

Bulk Electrolysis Experiments. Bulk electrolysis experiments were performed using an
EG&G Princeton Applied Research 273 potentiostaUgalvanostat in CH2C12/0.1 M
Bu&lBF4 solutions. The electrolytic cell divided into three compartments with a fine
porosity glass frit between the compartments (Figure 2.2). The main compartment
contained a cylindrical platinum mesh working electrode and Teflon stir bar centered
within the platinum mesh. The other two compartments contain the platinum counter
electrode and the silver-silver chloride reference electrode.
The electrolytic cell was assembled after oven drying at 110' C. A CH2C12/0.1 M

BQNBF~solution was introduced into the cell, stirred, and degassed with nitrogen for 10
minutes. Auranofin was added (10 to 20 mg) and the solution was stirred and degassed
for 10 minutes.

The total number of electron equivalencies (n) passed was calculated by assuming
that the background current constant during the electrolysis experiment. The total number
of coulombs (Q

=

I x time) was subtracted from the total number of coulombs passed

during the experiment (Qtotal):

N = (Qtotai-Qbackground)/(F)(MOl)

F = Faraday constant.
Mol = number of added Auranofin moles.
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Figure 2.2. Cell for bulk electrolysis experiments
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Results
Cyclic Voltammetry Experiments. The results of cyclic voltammetry experiments on

Auranofin are shown in Figure 2.3. Figure 2.3 a-b are the current-voltage responses for 1
mM Auranofin in 0.1 M BqNBF4/CH2C12 solutions at scan rates of (a) 50 mV/s and (b)

500 mV/s, respectively. In each CV, there are two anodic processes. In Figure 2.3a they

occur at about

+ 1.1 V (vs. Ag/AgCl) and +1.6 V, while in Figure 2.3b, they occur at

somewhat higher potentials. The two redox processes were found to be irreversible at all
scan rates, concentrations, and switching potentials (e.g. +1.2 V) investigated. Both
processes appear characteristic of an EC mechanism, with the following reaction being
quite fast. CV experiments with ferrocene, a reversible one-electron redox couple, at 50
mV/s and 500 mV/s show a potential shift of similar magnitude as seen for Auranofin
(Figure 2.3a-b). This result suggests that the shift originates from the electrochemical cell
used, such as from cell resistance (iR drop), and not from kinetic effects of a following
reaction.
Figure 2.4a-c shows the effect of change of concentration as well as of
electrolyte. The current-voltage response for 1 mM Auranofin in 0.1 M Bu&Jl"PdCH2C12
solution at scan rates of 50 mV/s is shown in Figure 2.4a. This CV is the result of the
same experimental procedure used to generate the CV for Figure 2.3a, except for a
change of electrolyte (BqNPF6 vs. BqNBF4). At first glance, the CV wave-shapes of
Figure 2.4a vs. 2.3a appear significantly different. However, close inspection of Figure
2.3a shows similar anodic processes to 2.3a, i.e. one starting at about +1.O V as well as
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Figure 2.3b. Cyclic voltammogram of 1 mM Auranofin using Pt working and auxiliary
electrodes and Ag/AgCl reference in 0.1 M Bu4N13F,/CH2C1, at 500 mV/s.
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one at +1.65 V. What is also apparent is the great diminution of the current response of
Figure 2.4a compared to Figure 2.3a. It has been previously demonstrated that the CV
wave-shapes for phosphine gold thiolate complexes are sensitive to the type of electrode
as well as to solvent owing to the effects of adsorption at the electrode.6 Repeated CV
cycling of Auranofin also leads to filming of the electrode, indicative of adsorption at the
electrode. Presumably, the filming process is affected during oxidation by the rate at
which oxidized (positively charged) complexes are removed from the surface of the
electrode. It is therefore not unexpected that changing the anion (PFL vs. BF4-) would
also effect the wave-shape. The data suggests that the PF; anion is not as efficient as BF4in keeping the electrode clear of oxidation products, leading to an increase in filming rate
and thus leading to a great reduction in the current response. The effect of increasing
concentration of Auranofin from 1 mM, 2 mM, and 4 mM is seen in Figures 2.4a, 2.4b,
and 2.4c, respectively. The increase in the current response of both oxidation processes
demonstrates that the observed electrochemistry originates from the analyte and not the
solvent or electrolyte. Cyclic voltammetry experiments were also performed on
Ph3PAu@-thiocresolate) under similar conditions used for Auranofin (0.1 M
B Q N B F ~ / C H ~ solutions
C~~
at scan rates of 50 mV/s) (Figure 2.5). The results allow
comparison to other electrochemical investigations reported for phosphine gold thiolate
complexes.6 The electrochemistry of gold(1) complexes with pyridine-2-thiolate was
investigated by Laguna and coworkers.6CThe gold@) cationic complexes [Au2(dppm)(ZpyS)]' and [Au~(dppe)(2-pyS)]' undergo irreversible oxidations at +1.42 V and +l.46 V
vs. SCE, respectively, during cyclic voltammetry experiments at a Pt disk
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Figure 2.5. Cyclic Voltammogram of 1 mM Ph3PAu(p-thiocresolate)using Pt working and auxiliary
electrodes and Ag/AgCl reference in 0.1 M Bu4NBF4/CH2C12at 50 mV/s.
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working electrode recorded at 200 mVs-' in 0.1 M BudWFdCH2C12 solution.6c
Bulk Electrolysis Experiments. Bulk electrolysis of Auranofin at +1.2 V vs. Ag/AgCl in

C ~ ~ that the first oxidation is 0.5 electron process (data
0.1 M B Q N B F ~ / C H ~ showed
based on 9 runs; 0.44, 0.65, 0.25, 0.6, 0.54, 0.54, 0.49, 0.38, and 0.61). The data supports
the irreversible oxidation at +1.1 V is due to a fast chemical reaction, which is the
oxidation of thiolate to the corresponding disulfide and rapid rearrangement of the gold
product to a cluster. Bulk electrolysis results on Auranofin at +1.6 V showed the process
is consistently >2 electrons. Completion of electrolysis experiments after the first
oxidation was checked by CV experiments. The first oxidation wave disappears
completely in the cyclic voltammogram of electrolysis product solution, while the last
oxidation remains almost the same as for the initial Auranofin cyclic voltammogram.
Figure 2.6 is an example of bulk electrolysis curve obtained during the experiment.

Discussion

This work reports oxidative cyclic voltammetry studies on Auranofin in a nonaqueous solvent (CH2C12). There are two oxidation processes that occur at +1.1 V and
+1.6 V. Both appear to be irreversible at all scan rates investigated (50-2,000 mV/s).
Table 2.1 shows the results of CV studies on Auranofin and related phosphine gold
thiolate complexes." All of the complexes show two irreversible oxidation processes that
are separated by 400-800 mV. The first oxidation process for the PPh3 and dppe
complexes have been assigned as a sulfur based oxidation.6a,b
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Table 2.1. Cyclic Voltammetry Data for Auranofin and Related Complexes.

Comp1ex

Oxidation

Auranofin

Reduction

Solvent

Ref. Elec.

Ref

+1.1 (irr)a

CH2C12

Ag/AgCl

b

+1.6

CH2C12

Ag/AgCl

b

SCE

4

-0.5 (rev)‘
Ph3PAu@-tc)
Au2(p-dppe)@-tc)2

+0.82 (irr)

CH2C12

Ag/AgC1

b

+l.50 (irr)

CH2C12

Ag/AgCl

b

+0.72

CH2C12

SCE

6a

SCE

6a

+1.54
Au2(P-dPPe)@dt)
Me3PAu@-tc)

+0.77

CH2Cl2

SCE

6a

+1.2

CH2C12

SCE

6a

+0.93 (irr)

CH3CN

Ag/AgCl

6b

+1.55 (in)

CH3CN

Ag/AgCl

6b

-

a. CV experiment at 1 mM Auranofin and 50 mVs-’ using 0.1 M Bu4NBF4 solution. b. This work.
b. Reversible at pH > 9; assigned to the Au”’ couple. d. Pt wire working electrode and 0.1 M TBAH solution;
scan rate of 50 mVs-’.
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Recent results from our laboratory on binuclear as well as on mononuclear
phosphine gold thiolate complexes indicate that after an initial one-electron sulfur-based
oxidation, the gold complex rapidly undergoes rearrangement to form a gold cluster and

'

disulfide.' This suggests the possibility that one-electron oxidation of Auranofin may
provide a pathway to higher molecular weight gold complexes as well as a mechanism to
increase disulfide concentration. Characterization of the one electron oxidation products
will be discussed in chapter 3
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CHAPTER 3

The Formation of a Gold(I) Cluster and Disulfide
From Oxidation of the Antiarthritic Gold Drug: Auranofin

Introduction

Gold compounds have been successfully used in the treatment of rheumatoid
arthritis (RA) for over half a century.’ The antitumor activity of gold compounds in
several tumor models such as P388 leukemia was also investigated.2 Recently a few
gold compounds showed high potency in the treatment of

Auranofin (‘Ridura’

from Smith Kline and French Laboratories) is one of the orally active groups of the
slow-acting anti-arthritic gold drugs, and is used mainly to delay progression of the
arthritis and prevent or reduce subsequent damage to the

joint^.^

Despite its extensive clinical investigation, the mechanism by which Auranofin,
2,3,4,6-tetra-O-acetyl-1-thio-p-D-glucopyranosato-S)(triethylphosphine)

goMI)’

inhibits rheumatoid inflammation and alters disease pathophysiology is poorly
understood.’y2This is mainly due to a lack of understanding of the etiology of the
arthritis disease.’ Previous studies on the interaction of gold drugs with albumin, a thiol
containing

protein,

identified

cysteine-34

as

the

preferred

binding

. ~ triisopropylphosphine oxide was obtained from triisopropylphosphi
site of g ~ l d ( I )Free
ne (2,3,4,6-tetra-O-acetyl- 1-thio-P-D-glucopyranosato-S)gold(I),an Auranofin
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analogue, in the reaction with serum albumin via a protein-bound phosphonium
intermediate.6

H

OAc

A
Figure 3.1. Structure of Auranofin showing numbering scheme for ring protons.

Auranofin, (Et3P)Au(TATG), TATG = Tetraacetylthioglucose, is monomeric,
lipid soluble, and nonconductive.' The X-ray structure shows that gold(I) is equidistant
between thiolate (Au-S

=

2.29

linkage is nearly linear (173.6

A) and phosphine (2.26 A) ligands and the S-Au-P

0).7

The Et3P unit plays a role in stabilizing the gold-

thiolate moiety.' The 1 9 7 AMossbauer
~
spectroscopy has been used successfully to
determine oxidation state, type of ligand, and degree of coordination of anti-arthritic
gold drugs.' The IS and QS values of Auranofin (3.55 and 8.64 mm s-l) are closer to the
characteristic values for bis(triethy1phosphine) gold (3.06 and 8.93 mm s-') than those
for the polymeric gold thiolate drugs (1.40 and 6.2 m m ~ - ' ) . ~
Studying the redox behavior of gold@) thiolate drugs emerged as an effective
approach in understanding their pharmaceutical effects in rheumatoid arthritis.5,9,10
Oxidizing conditions in vivo are believed to play a role in the therapeutic effect of the
anti-rheumatoid drugs.5,9,10 In plasma the thioglucose moiety undergoes exchange with
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other thiolates and the triethylphosphine ligand releases to form the very stable Et3PO.'
Sadler et. a1 reported on the formation of Et3PO from Auranofin in the presence of
albumin.' Colloidal gold and gold(I), in the presence of oxygen and penicillamine,

'

undergo a redox reaction of importance in crysotherapy models.' Chemical oxidation of
Auranofin by hypochlorite, a strong oxidant released by phagocytic cells, has been
studied by Shaw et. a1.l' Sulfonate and the very stable Et3PO formed first followed by
oxidation of gold(1) to gold(III)." Biooxidation of metals other than gold(1) is known
such as Hg(0) oxidation to Hg(II) in vivo.I2
A recent review of the electrochemistry of gold and silver complexes shows that
studies of the redox behavior of gold compounds related to medicinal effects are still
1a~king.l~
The electrochemical reduction of Auranofm in C2H50H/H20 reported at -0.5
V vs. SCE, involves one electron reduction, i.e., Au".'~ The oxidation of Auranofin in

0.1 M Bu&BF4/CH2C12 solution was reported recently. There are two irreversible
processes at 1.1 and 1.6 V vs. Ag/AgCl (Chapter 2)." Hemple et. a1 studied the effect of
aqueous HC1 on Auranofm, (Et3P)Au(TATG), TATG = Tetraacetylthiglucose, to mimic
its behavior in stomach acid.I6 The ionic [(Et3PAu)2(TATG)]Cl was proposed as one of
the products; however, trials to isolate the ionic structure resulted only in
(Et3P)Au(TATG) and

E t 3 P A ~ c l . l ~The

formation

of

the

ionic

complex,

[(Et3PAu)z(TATG)]Cl, involves two reversible steps; the first step involves formation
of Et3PAuCl with the stability constant, K1 = 4.6 x

M-' and the second step involves

formation of the ionic digold complex with the stability constant, K2 = 2.0 x lo3 M-' in
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water at 37' C while K1
methanol/water.

=

7.8 x

M-' and

K2 =

1.3 x lo2 M-' in 50 %

'

A thorough examination of Chemical Abstracts showed many trials to detect
disulfide as a possible product from the redox reactions of gold(1) thiolate drugs. 10,17,18,19
Formation of disulfide along with gold(0) from Solganol, (aurothioglucose) in aqueous
medium was proposed by Shaw

Regliniski et. a1 studied the disulfide produced

from Myochrysine (aurothiomalate) as a source of oxidative stress in arthritic patients."
Chemical and electrochemical results from our lab indicated formation of a
gold(1) cluster and disulfide upon oxidation of phosphine gold(I) thiolates in nonaqueous medium.' The irreversible electrochemical oxidation processes of Auranofin
imply a possible chemical change upon oxidation, i.e., an EC mechani~rn.'~
We decided
to investigate the possible redox activity at the thiolate center using the well-known oneelectron oxidizing agent, [CplFe]PF6, which has an oxidation potential comparable to
the thiolate center in Auranofin.20 The results of the oxidative study on the thiolate
center in Auranofin, which are presented in this chapter, may help to understand the
possible sources of toxic and therapeutic effects.

Experimental Section
Materials. All solvents are reagent grade and used without purification. Auranofin was

purchased form Pfanstiehl, IL.HAuC14 is a gift from Johnson Matthy. Et3PAuCl was a
gift from Dr. David T. Hill, Temple University. AgN03, CF$03Ag, AgPF6, and AgBF4
were purchased from Aldrich. Oxidized glutathione for disulfide exchange experiments
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was purchased from Sigma. Solvents for NMR studies, CDC13, D20, and DMSO were
purchased form Aldrich. [Cp2Fe]PF6 for chemical oxidation was purchased from
Aldrich and was finely grounded before use.

31P NMR Measurements. The 3'P{'H}NMR resonances were recorded at 81 MHz
using a Gemini 300 spectrometer. The 31PN M R chemical shifts were referenced to an
external sample of 85% H3P04.

'H NMR Measurements. The 'H NMR resonances were recorded at 81 MHz using a
Gemini 300 spectrometer. Chemical shifts were measured relative to the solvent
resonance at room temperature. About 10 mg of the desired complex was dissolved in
CDC13 and spectra were recorded directly. In the chemical oxidation studies a downfield
shift for the triethylphosphine ligand was noticed with some overlapping with the
resonances for the tetraacetyl groups on the thioglucose ligand. Thus this upfield
(aliphatic) region is not very informative. Data will be reported for the downfield region
only, which corresponds to H 1-H6 of the thioglucose ligand.
Electrochemical Experiments. All electrochemical measurements were undertaken at

room

temperature

using

an

EG & G

Princeton

Applied

Research
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potentiostat/galvanostat under computer control. Measurements were carried using the
same procedure as described in chapter 2 and Figure 2.1.

ESI FT-ICR Mass Spectrometry. Mass spectroscopy studies have been carried out by
Dr. Touradj Souloki, Department of Chemistry, University of Maine. The ESI FT-ICR
mass spectra were acquired with an IonSpec FT-ICR mass spectrometer equipped with a

7 T superconducting magnet (IonSpec Corp., Irvin, CA) and IonnSpec99 software. A

53

stock solution of Auranofin or its cluster was prepared by dissolving 1 mg of the sample
in 50:50 methanol: water solution (1 mg/ml, -0.5% acetic acid).

Oxidation of Auranofin by [CpzFe]PF6 (one electron oxidation): To 500 mg (0.73
mmol) of Auranofin dissolved in 100 ml CH2C12 under nitrogen was added 122 mg
(0.36 mmol) of [Cp2Fe]PF6 (1:OS).

Stirring continued for 24 hr until the blue color of

ferrocenium disappeared and a yellow color of ferrocene formed. The solvent was
evaporated in vacuo and the residue was washed with ether (3X) to remove CpzFe. The
remaining off-white solid was recrystallized by dissolving in a small amount of CH2C12

(3 ml), followed by addition of ether or hexane.

Independent Synthesis of the Digold p-thiolato, [(R3PAu)z(TATG)]X (R = Et, Me;

X = PFC, NO;, CF$OY, BFi). 1 mmol of AgX was dissolved in 10 ml CH3CN or
C~HSOH
and was added slowly to 1 mmol of Et3PAuCl or Me3PAuCl dissolved in 10
ml CH2C12 at 0' C. Stirring of the mixture at 0' C for 30 min continued in the dark and
AgCl was then filtered on celite. The filtrate was reduced to 3 ml in vacuo and ether was
added to form a white precipitate of Et3PAuX which was filtered and washed with ether.

To 1 mmol of (Et3P)Au(TATG) or (Me3P)Au(TATG) dissolved in 10 ml CH2C12 was
added 1 mmol of Et3PAuX or Me3PAuX, respectively, dissolved in 10 ml CH2Cl2 and
the mixture was stirred for 30 min at 0' C. The mixture was reduced to 5 ml in vucuo
and ether was added to give an off-white precipitate. The sample was recrystallized by
diffusion of ether into methylene chloride and dried over P205 in vucuo for 24 hrs.
Elemental analysis calculated for [(E~~PAu)~(TATG)]NO~,
C 29.57, H 4.64, Found, C
29.14, H 4.60. 'H NMR (300 MHz; CDC13) 1.2 (18H, dt, PCH~CHJ),1.85-2.1 (24, m, 4
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OAc + 6 PCH2CH3), 4.0 (2H, m, H5), 4.25-4.30 (2H, dd, H6), 5.0-5.15 (2H, m, H2-H4),
5.50 (lH, d, Hl); 31P {'H}"IR (300 MHz, CDC13) 36.5 ppm. Elemental analysis
calculated for [(Me3PAu)*(TATG)]N03.ether:C 26.17; H 4.16. Found, C 26.13; H 4.01.

'H NMR (300 MHz; CDC13), 1.2 (18H, d, PCHj), 2.0-2.1 (12, 4s, 4 OAc), 3.9 (2H, m,
H5), 4.20-4.25 (2H, dd, H6), 5.0-5.2 (3H, m, H2-H4), 5.35 (lH, d, Hl); 31P{'H}NMR
(300 MHz, CDC13)-0.17 ppm.

Synthesis of Bis(tetraacetylthiog1ucose). 0.5 ml of

12

(0.93 M in acetonitrile) was

added to 1.00 ml of HSATg (0.41 M in acetonitrile). After stirring for two minutes, the
deep brown solution was titrated with 0.2 ml of double distilled water to a light yellow
color, stirred for 10 min and then poured into 80 ml of cold aqueous KI solution (1.0

M). The solution was filtered and the precipitate was washed with water and dried.21

Trials to Grow X-ray Quality Crystals. The procedures involved in growing X-ray
quality crystals of digold p-thiolato cluster obtained by oxidation of Auranofin were
meticulous and time consuming. Patience and persistence were the keys to success!. A
variety of different solvent combinations, such as ether-methylene chloride, hexanesmethylene chloride, ether-chloroform, and cyclohexane-ethyl acetate (was used to
obtain crystals of Auranofin) was used.' In all-solvent mixtures the crystals were either
very fine needles or no crystals formed even after two months. Another approach
involving slow evaporation of methylene chloride, chloroform, or water yielded oily
residues.
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The other approach involved changing the counter anion; PF;,

NO3-, BF4-,

CF3S03-, and Sn(Ph)2(NO);’- were all tried. Using P F i and B F i appeared to give oils or
decomposition. Using CF3S03- yielded crystals that were yellowish-white and changed
to orange-brown over time. The counter anion Sn(Ph)2(NO)32-failed to replace the
original nitrate counter ion as evidenced by the absence of aromatic resonances in the ‘H

NMR. The best counter anion was N03- in terms giving stable crystals, although they
were small. The nitrate was promising also in terms of trials conducted previously by
Dr. David Hill, who obtained acceptable crystals but the X-ray studies showed disorder
in the final structure.22
The magic bullet was changing the triethylphosphine to trimethylphosphine
ligand in Auranofin. The crystals were dissolved in 3 ml and 20 ml of ether was added
slowly without disturbing the solution. The crystals were grown by forming a colloidal
state at room temperature first. The procedure involves sealing the test tube with a cork
and inserting a needle to evaporate some of the solvent over a period of two days. The
needle was then removed and the mixture was left for two days. The procedure was
repeated for two months until a colloidal state formed and the mixture was left without
disturbing. Finally X-ray quality crystals were obtained from the colloid as plates and
needles.
For X-ray examination and data collection, a suitable crystal, approximate
dimensions 0.36 x 0.08 x 0.07 mm, was mounted on the tip of a glass fiber. X-ray data
was carried out by Dr. J. Krause Bauer, Department of Chemistry, University of
Cincinnati. Intensity data were collected at 150K on a Siemens SMART 1K CCD
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diffiactometer (platform goniostat with

x

fixed at 54.69', sealed-tube generator,

graphite-monochromated Mo k a radiation, h = 0.71073 A). The structure was solved
by a combination of the Patterson method using SHELXTL v5.1 and the difference
Fourier technique and refined by full-matrix least squares on F2 for the reflections
diffracting out to 0.75

A. Non-hydrogen atoms were refined with anisotropic

displacement parameters. Weights were assigned as w-*= u2 (F):
=

0.0487, b

=

33.7775 and p

=

0.33333F:

+ 0.66667F:.

+ (ap)2 + bp where a
Hydrogen atoms were

calculated based on geometric criteria and treated with a riding model. Hydrogen atom
isotropic temperature factors were defined as U(C)*a

=

U(H) where a

=

1.5 for

methyls and 1.2 for others. [(M~~PAu)~(TATG)~]~(NO~)~
crystallizes with a badly
disordered solvent which appears to be multiple H20 molecules or highly disordered
Et2O. A suitable disorder model could not be resolved, thus the solvent contribution
was subtracted from the reflection data using the program SQUEEZE. The refinement
converged with crystallographic agreement factors of R1 = 6.44 %, wR2 = 1 1.52 % for
61 14 reflections with I 220 (I) (R1

=

9.58 %, wR2= 13.02 % for all data) and 3 14

variable parameters.

Results and Discussion
Chemical Oxidation Products. Upon addition of [Cp2Fe]PF6 to Auranofin (0.5: l), the
characteristic blue color of [Cp2Fe]PF6 changed slowly to yellow-orange due to
formation of ferrocene. Stirring continued for 24 hr until the blue color of [Cp2Fe]PF6
disappeared and the solution was yellow. The solvent was evaporated in

V ~ C U Oand

the
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residue was washed with ether (3X) to remove Cp2Fe and disulfide. The remaining offwhite solid was recrystallized by dissolving in a small amount of CH2C12 (3 ml),
followed by addition of ether or hexane. After work-up of the solution, the 'H NMR of
the isolated product showed a larger chemical shift at H1, relative to Auranofin,
compared to other protons in the thioglucose unit.
1

H NMR Studies of Auranofin and the Oxidation Products. The resonances for the

ring protons (Hl-H6, Figure 3.2) on the thioglucose ligand in Auranofin and related
structures have been unambiguously assigned.23The thiolate resonances are a secondorder pattern due to long-range virtual coupling.23Monitoring the resonance shift of HI
is an efficient approach for detecting coordination to gold(1). For example, replacing H+
of protonated tetraacetylthioglucose by [Au(PEt3)]+, to form Auranofin (Table 3. l),
produces a coordination shift (A

= G

~

~- 8Tetraacetylthioglucose
~
~
~
f
i

at ~H1) of 0.60 ppm in

CDC13.23The downfield chemical shift of H1 is due to the electron density increase on
the sulfur atom of the thioglucose ligand when it is coordinated to gold(1). Oxidation of
the thiol to the corresponding disulfide is accompanied by the appearance of a doublet at

4.65 ppm in the disulfide and the disappearence of the SH resonance at 2.3 ppm (not
shown in Table 3.1) and the triplet at 4.54ppm in the thiol. 'H NMR data for Auranofin,
thioglucose, disulfide, and digold p-thiolato cluster are reported in Table 3.1. The
products of oxidation of Auranofin with [Cp2Fe]PF6 (Equation 3.1) were identified as
[(Et3PAu)2(TATG)]PFs, (TATG)*, and CpzFe by comparison to authentic samples.
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Table 3.1. 'H NMR data in the downfield region for Auranofin, TATG, (TATG)z, and

[(Et3PAu),(TATG)]X, with various counter ions in CDC13.
Compound

H1

H2-H4

H5

H6

Auranofin

5.14(d)

4.94-5.09

3.71

4.07-4.28

TATG

4.54(t)

4.96-5.22

3.73

4.10-4.30

(TATG)2

4.65(d)

4.96-5.40

3.80

4.20-4.38

[(E~~PAU)~(TATG)]PF~ 5.25(d)

5.00-5.14

3.96

4.10-4.25

[(E~~PAu)~(TATG)INO~ 5.50(d)

5.00-5.15

4.00

4.25-4.30

[(E~~PAu)~(TATG)]CF~SO~
5.25(d)

4.95-5.15

3.80

4.10-4.30

2EbPAuTATG + [Cp2Fe]PF6

--+ [(&PAu)2(TATG)]PF6

+ (TATG)2 + Cp2Fe 3.1

The digold p-thiolato cluster was prepared according to Scheme 3.1, where R =
Me, Et. The disulfide, bis(tetraacetylthioglucose), was prepared by oxidation of
tetraacetylthioglucose with I2 (Equation 3.2).
2HTATG + I2

-+

(TATG)2 + 2 r + 2 w

3.2

~
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The 'H NMR spectrum of [(Et3PAu)2(TATG)]PFsis shown in Figure 3.3 and the
1

H NMR of bis(tetraacetylthiog1ucose)is shown in Figure 3.4.
The 'H N M R data for resonances in Auranofin, disulfide, and the digold p-

thiolato cluster with different counter anions are reported in Table 3.1 and illustrated in
Figures 3.2, 3.3, and 3.4. Generally, a downfield shift for the thiolate protons was
noticed in the digold p-thiolato cluster spectrum. Comparing this spectrum (Figure 3.3)
to Auranofin (Figure 3.2), the remote hydrogens (H2-H6) from the thiolate center shift
downfield without a change in the splitting pattern. The appreciable shift at H1 (A6 =

0.21-0.38 ppm) in the digold p-thiolato cluster indicates the change in coordination of
the thiolate center.
The spectrum of the crude oxidation product mixture contains an additional
doublet at 4.65 ppm (Hl), assigned as H1 in the disulfide (Figure 3.4). The spectrum of
the crude mixture (Figure 3.5) is a combination of the disulfide and the digold p-thiolato
cluster. Both of the multiplets at 3.85 (H5) and 4.2 (H6) are formed in the crude product
and the disulfide. Assignment of the peaks due to disulfide or cluster was confirmed by
mixing the disulfide and digold p-thiolato cluster in a 1:l ratio and comparing the
spectrum of this mixture product after chemical oxidation. The presence of a combined
mixture fiom the cluster and the protonated thioglucose due to possible hydrolysis can
be excluded due to the absence of the triplet (Hl) at 6 = 4.54 ppm and the doublet (SH)
at 6 = 2.3 ppm.
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Solvent dependence of the cluster is also apparent, similar to Auranofin.23

IH

NMR of the [(Et3PAu)2(TATG)]N03 in D20 showed an upfield shift of H1 to 5.6 ppm
in addition to a small shift in other resonances. In DMSO the resonances showed a
distinct feature not only downfield shifted but also showed a better resolving of
overlapped resonances.

31P{'H}NMR of [(Et3PAu)z(TATG)]X. Previous studies showed that the 31Pchemical
shift is very dependent on the environment in gold compounds.21,23,24 Due to its
sensitivity to a change in coordination and geometry in groups in the trans position, 31P

N M R has been used eficiently in monitoring the interaction of gold drugs with
biological systems. 31P N M R has been used to provide information concerning the
behavior of red cells in DzO/saline in the presence of Auranofin and monitoring the
The 31PN M R spectrum of AlbSAuPEt3 in
interaction of Et3PAuCl with gl~tathione.~'
the presence of Et3PAuC1, in aqueous buffered solution at pH 7.9, contains a resonance
at 36 ppm (Table 3.2) assigned to the reversibly formed species AlbS(A~PEt3)2.~l
Figure

3.6

illustrates

[(Et3PAu),(TATG)]X, X
[(Et3PAu),(TATG)]NO,

=

the

31P NMR

spectra

of

Auranofin

and

P F i and NO3-, in CDC13. Both Auranofin and

gave rise to sharp 31P Nh4R resonances. The Auranofin

spectrum shows a resonance at 38 ppm; however the gold cluster spectrum contains an
upfield resonance at 37 ppm or 36 ppm depending on the counter anion and the solvent.
The chemical shift (66) of 1 -2 ppm was also seen in the related clusters,
[(PPh3Au)2(SC6&CH3)]?

and [dppeAu2(SCg&CH3)]22',

reported previously by our

group.2631PNMR spectra of all clusters at room temperature showed
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Table 3.2. 31PNMR chemical shifts of Auranofin, [(Et,PAu)z(TATG)]X,
and related complexes.
Complex

6, PPm

Solvent

Ref.

Auranofin

38

CDC13

a

[(E~~PAu)~(TATG)]PF~

37

CDC13

a

[(E~~PAu)~(TATG)]NO~

36.5

CDC13

a

[(E~~PAu)z(TATG)INO~

36

D2O

a

AlbSAuPEt3

38.8

D20

21

[AlbS(AuPEt3)2]+

36

D20b

21

[A~(PEf3)21'

44

D20b

21

a. Our data; relative to 85% H3P04 in D20. The chemical shifts
quoted are reproducible to k 0.1 ppm. b. In aqueous buffered solution at
pH = 7.9; relative to (Me0)3PO.

The upfield chemical shift in [(Et3PAu)2(TATG)]+ compared to Auranofin is an
indication of the greater trans influence imposed by the p-thiolate groups, i.e., the
greater the trans influence of the p-tetracetyl thioglucose units the weaker the trans Au-P
bond and the more upfield the 31Pchemical

It is noticeable that no resonance

observed due to free Au(PEt3); (44 ppm) or any other phosphine species is observed at
room temperature. Ab initio study of structures and energetics of sulfur-bridged copper
clusters [ C U ~ ~ S ~ ( P(nR =~ )1-4,
~ ] 6; m

=

0, 2, 4, 6, 8; R= H, CH3) predicted that the

tertiary phosphine ligands are the reason for the stability of this class of clusters.27
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Titration of Et3PAuN03 with Auranofin in CDC13 was followed by
3'P{'H}NMR (Figure 3.7). The results showed that when either Et3PAuN03 or
Auranofin is present in excess only a sharp single peak is observed due to rapid ligand
exchange among the Et3PAu' species present. When the ratio of AuranofmEt3PAuN03
<1 the observed peak is broad. At the equivalence point, ([Et3PAuN03] = [Auranofin]),

the characteristic peak for the cluster is obtained at the same chemical shift as the pure
sample.
Effect of Counter Ions on Chemical Shifts. 'H NMR. It is noteworthy that the H1
resonance shifts upon changing the counter anion, which supports to a limited extent,
the possibility of counter anion interaction with the digold p-thiolato cluster. In the case
of X

PF;,

= NO;

(Figure 3.8), H1 shifts to 5.5 ppm in comparison to 5.25 ppm when X

=

CF3S03-, or BFi. Generally the peaks shifted and broadened on going from

Auranofin to the cluster, especially when X = NO). The region of 5.0 to 5.5 ppm, which
contains Hl-H4 splits into three groups in the cluster. For example when X

=

P F i or

CF3S03-, H4 is centered at 5.02 ppm (Figures 3.3 and 3.9). In the isolated product, X =
PFi, NO3-, or CF3S0<, the first and second groups did not show further splitting;
however, the third group appears as a doublet in the range of 5.25-5.50 ppm as shown in
Table 3.1 and Figures 3.3, 3.8, and 3.9.
The largest shift was noticed in H1 in case X = NO3-.The simple explanation for
this noticeable shift, compared to other counter anions, is due to the interaction of NO<
with H1 through hydrogen bond.
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F

fl

Figure 3.7. 31PNMR spectra of Auranofin, Et3PAuN03,

and their mixtures in CDC13 solutions. The mole ratios
of Auranofin:Et3PAuN03 are (A) 1 :0, (B) 0.66:0.34,

(C) 0.5:0.5, @) 0.39:0.61, (E) 0.20:0.80, and (F) 0:l.
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b) 31PNMR. Both Auranofin and the digold p-thiolato cluster with PF; counter anion
gave sharp 31PNMR resonances at 38 and 37 ppm, respectively (Figure 3.6). A broad
peak at 36.5 pprn was noticed in [(Et3PAu)2(TATG)JNO3-.In X
showed a sharp peak at 37 ppm as in X

=

=

CF3S03-, 31P Nh4R

PF;. The higher shift and broadness in 31P

NMR,X= NO3-, supports to a limited extent, the possibility of counter anion interaction
with the digold p-thiolato cluster, which was noticed also in 'H NMR studies.

Electrochemical Oxidation Studies. As previously discussed, Auranofin irreversibly
oxidizes at potentials of 1.1 and 1.6 V vs. Ag/AgCl in 0.1 M BLkJ"JBF4/CHZC12 solutions
(Chapter 2 and Figure 2.3). The CV wave-shapes of phosphine gold thiolate complexes
are sensitive to the type of electrode and solvent due to adsorption effects at the
e l e c t r ~ d e . ' ~The
, ' ~ electrochemical response of Auranofin at 1.1 V vs. Ag/AgCl is
sensitive to the nature of the supporting electrolyte.I s
The electrochemical oxidative behavior of [(E~~PAu)~(TATG)]NO~
was
investigated by using cyclic voltammetry (CV) in 0.1 M B Q N B F ~ / C H ~ solutions
C~~
using Pt working and auxiliary electrodes and Ag/AgCl reference. Cyclic
voltammograms of [(Et3PAu)2(TATG)]NO, as a function of scan rate and concentration
are shown in Figures 3.10 and 3.11.
It is of interest to compare the oxidation potentials of Auranofin with that of the
cluster. The isolated cluster showed only the second irreversible peak with a small shift
to 1.65 V vs. Ag/AgCl. However, at similar concentration and scan rate, the current
decreased from Auranofin to the cluster. The peak at 1.65 V showed dependence on

73

Current (p4)

fs

0

74

Current (pA)

E

0
0

75

concentration and scan rate (Figure 3.10 and 3.11). Cyclic voltammetry of the crude
product following the complete oxidation of Auranofin using [Cp2Fe]PF6 showed a
reversible peak at 0.35 V, assigned for ferrocene, in addition to a peak at 1.65 V assigned
for the cluster.

Mass Spectroscopy Studies.
Mass spectroscopy studies have been carried out by Professor Touradj Solouki,
Department of Chemistry, University of Maine. Mass spectroscopy studies on
Auranofin and its digold p-thiolato cluster (Figure 3.12 and 3.13) were carried out in
5050 methanol: water, with 0.5% acetic acid by using ESI -1.7 keV, soft ionization,
and positive ion Mo. The digold p-thiolato cluster, [(Et,PAu)2(TATG)]N03, showed a
peak at m/e 993 as the parent peak in addition to another peak at m/e 994 assigned to the
cluster + H' species (Figure 3.12). The ESI studies showed that the cluster is stable and
no peaks due to decomposition products have been noticed. Specifically a peak at m/e
679, which would correspond to Auranofin was not observed.
Mass spectroscopy studies on Auranofin were carried out by using ESI -1.7
keV, soft ionization, and positive ion Mo in 5050 methanol: water with 0.5% acetic
acid. The spectrum showed peaks at m/e 679, 1553, and 1671 (Figure 3.13).
Unexpectedly, the Auranofin peak at m/e 679 is not the major peak in the spectrum
rather the peak at m/e 993 for the digold p-thiolato cluster is the major peak. The peaks
at

m/e

1553

and

1671

are

assigned

to

[(E~~P)~(Au)J(TATG)~]+
and

[(Et3PAu)3(TATG)zlLf,respectively. A simple explanation for these unexpected results

~
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in the ESI studies of Auranofin is probably due to the acetic acid used which may have
protonated the thiolate, allowing for formation of the digold p-thiolato cluster according
to Equation 3.3.16
2 Et3PAu(TATG) + H' __+ [(Et3PAu)2(TATG)lf + HTATG

3.3

Disulfide Exchange Studies. Previous studies in our group on the disulfide exchange
reaction between gold(1) thiolates and disulfides showed dinuclear gold(T) thiolates
reacted with disulfides faster than mononuclear gold(1) thiolates.'
The tetranuclear gold(I) cluster, [(PPh3Au)4(SC&CH3)2] [PF6], formed after
chemical oxidation of PPh3Au(SC&CH3) was allowed to react with (sc6&c1)2 and
the unsymmetrical disulfide, ClC6&SSC6&CH3, appears to form first followed by the
symmetrical disulfide, (SC&CH3)2.

Interestingly, the disulfide exchange reaction

between the cluster and disulfide was found to be faster than the neutral gold@) thiolate
complexes.26
Auranofin cluster was allowed to react with glutathione disulfide, in D20 and
the reaction was monitored for 7 days. Figure 3.14 and 3.15 show the 'H NMR of
glutathione and digold p-thiolao, [(E~~PAu)~(TATG)]NO~
in D20, respectively. The
spectra of the reaction mixture are complex. Therefore I chose to compare
9

8

7

( H2N-CH-CH2-CH2-CO-

COOH
I
10

6

4

5

NH-CH-CH2-SS- ~
Lo
I

NH
I
2 CH2COOH
1

Glutathione disuhide
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the shift in H1 in [(Et3PAu)2(TATG)]NO3 at 5.6 pprn and H5 in glutathione disulfide at
3.3 ppm. The reason for this choice is that these hydrogens are both close to the sulfur
atoms, i.e. the disulfide exchange centers. The doublet of doublet at 3.3 ppm in
glutathione disulfide showed a slight upfield shift after 16 hrs and a new multiple
appeared at 3.4 pprn (Figure 3.16). After about 7 days the peak at 3.3 ppm had
decreased and the peak at 3.4 ppm had increased. There was no further change after 7
days. The peak at 5.6 ppm in [(Et3PAu)2(TATG)]N03 broadened and showed a
negligible shift after 7 days. That the reaction was very slow and further studies are
needed to clarify the nature of the reaction.
X-ray Studies of [(Et3PAu)*(TATG)]N03 and Related Structures. The mononuclear
gold thiolate complex PPh3Au-p-tc, similar to Auranofin, forms a tetranuclear gold
cluster and disulfide upon oxidation by [cp~Fe]PF6.'~
X-ray data shows equi-distant
gold atoms with a bridging thiolate bisecting the gold atoms in each unit. The four gold
atoms form a square with Au ...Au distances of 3.15

A

and 3.17

Fackler et al.

reported the X-ray structure of [ ( P ~ ~ P A u ) ~ S C H ~ P ~ ]as
~ (aNdimeric
O ~ ) ~ structure with a
strong gold-gold interactions of 3.07 and 3.12 A.28
Hill et al. obtained preliminary data on the solid state structure of

[ ( E ~ ~ P A U ) ~ ( T A T G ) ] ~ (in
N Owhich
~ ) ~ two gold atoms coordinate to one sulfur (Figure
3.17). In addition, the structure shows the two ionic units arranged in a square dimer
composed of four gold atoms all approximately equidistant. The sulfur atoms are on
opposite sides (trans) of the gold square bisecting the two phosphorous atoms above
them.
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P4

Figure 3.17. Crystal structure of product of reaction of Auranofin and
Et3PAUN03.22
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The Au-S-Au angles are approximately 88' and are somewhat compressed. This
compression may be due to the gold-gold interaction. The Au.. .Au distance was found
to be 3.2 8, with Au-S and Au-P bond lengths ranging from 3.34 to 2.39 8, and 2.19 to
2.35

A, respectively. Unfortunately, The quality of the data

was not high enough to

completely solve the structure, so it was never published.22
Crystal Structure Analysis of [ ( M ~ ~ P A u ) ~ ( T A T G ) ] ~ ( NAs
O ~ )discussed
~.
in the

experimental part,

multiple

attempts to

grow X-ray quality crystals for

[(E~,PAU)~(TATG)]~(NO~)~
showed a very limited success. Changing the counter
anions from P F i to NO3-, BFi, CF3S03-, or Sn(Ph)~(N03)3-failed to produce X-ray
quality crystals. A variety of different solvent combinations yielded very fine needles
or no crystals. Trials to grow crystals by slow evaporation of CHCl3, CH2Cl2, or H20
yielded oily residues.

* H N M R and elemental analysis showed that both [(E~~PAu)~(TATG)]~(NO~)~
and [(M~,PAU)~(TATG)]~(NO~)~
contain 2 PR3, R = Et or Me, per TATG. Synthesis of
both derivatives was achieved as shown in Scheme 3.1. Comparing 'H NMR of

[(E~~PAu)~(TATG)]~(NO~)~
(Figure 3.3) with [(M~~PAu)~(TATG)]~(NO~)~
(Figure
3.18) , the former showed H1 at 5.35 vs. 5.5 ppm for the later.
Good quality X-ray crystals were achieved by replacing triethylphosphine by
trimethylphosphine and crystals were grown from CH2C12-ether as described in the
experimental part.
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Crystals of [(M~~PAU)~(TATG)]~(NO~)~
were obtained as colorless plates and
needles fiom CH2C12-Et20. Crystal data, data collection and processing parameters are
reported in Table 3.3. Selected bond lengths and angles are listed in Table 3.4.
The molecular structure of [(M~~PAU>~(TATG)]~(N~~)~,
is shown in Figure
3.19 and 3.20. The molecular and crystallographic symmetries coincide running
through the center of the cation and anions (N1 and N2 of the nitrate ions lie on special
positions). The gold-gold distances are Aul-Au2= 3.1062(7), Aul-AulA= 3.1713 (1 1)
and Au2-Au2A= 3.1446( 12) A.
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Table 3.3. Crystal data and structure refinement for [ ( M ~ ~ P A u ) ~ ( T A T G ) ] ~
(No3)2.
Empirical formula

C40H74A~4N2024P4S2

Formula weight

1942.88

Temperature

150(2) K

Wavelength

0.71073 A'

Crystal system, Space group

Tetragonal

Unit cell dimensions

a = 26.1758(6)&

b = 26.1758(6)A,
c = 9.7781(3)81
Volume, Z

6699.7(3) A3, 4

Density( calculated)

1.926 Mg/m3

Absorption coefficient

8.957 mm"

F(000)

3712

Crystal size

0.36 x 0.08 x 0.07 m

8 range for data collection

2.46 to 28.31

Limiting indices

-34<h<32,-34<k<30,-13<1<11

Reflections collected

44007

Independent reflections

8321 (Rint = 0.1028)

Refinement method

Full-matrix least-squares on F2

Datahestraints / parameters

7403 I 0 I314

Goodness-of-fit on F2

1.099

Final R indices [I>20(I)]

R1 = 0.0644, wr2 = 0.1 152

R indices (all data)

R1 = 0.0958, wR2 = 0.1302

Largest diff. Peak and hole

1.205 and -1.018 eA-3
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Table3.4.

Selected

bond

lengths

(A)

and

angles

(0)

for

[(Me3PAu)2(TATG)]2(N03)2.

Au( 1)-P( 1)

2.259(4)

Au( 1)-S(1)

2.334(3)

A u (1)-A u (2)

3.106(7)

Au(1)-Au(l)#l

3.171(11)

A u (2)-P( 2)

2.270(4)

Au(2)-S(l)

2.355( 3)

Au(2)-Au(2)#1

3.144(12)

P( 1)-C( 15)

1.76(2)

P(1)-C( 16)

1.76(2)

P(2)-C( 17)

1.78(2)

P(2)-C( 19)

1.74(2)

P(2)-C( 18)

1.78(2)

P( 1)-Au(1)-S(1)

176.94(14)

P( l)-Au( l)-Au(2)

128.17(12)

S(l)-Au( l)-Au(2)

48.81 (8)

P(l)-Au( 1)-Au(1)

95.57(10)

S( 1)-Au(1)-

84.12(8)

Au(~)-Au(
l)-Au( 1)

89.74(2)

P(2)-Au(2)-S( 1)

175.1(2)

P(~)-Au(~)-Au(
1)

127.03(13)

S( l)-Au(2)-Au( 1)

48.22(8)

P ( ~ ) - A u ( ~ ) - A u ( ~ ) 95.65(11)

S(l)-Au(2)-

85.86(8)

Au( l)-Au(2)-Au(2)

90.23(2)

C(15)-P( 1)-C(16)

105.3(9)

C(1)-S(l)-Au( 1)

103.1(4)

C( 16)-P( 1)-C(17)

104.6(9)

Au( 1)-S(l)-Au(2)

82.96(10)

O( lO)-N( 1)-O( 12)

127.2(3)

O(l0)-N(1)-O(l1)

1 lO(5)

O(12)-N( 1)-O(11)

1 16(5)

O( 13)-N(2)-0( 14)

1 1 l(2)

Au(l)#l

Au(2)#1
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Conclusions

The present study clearly demonstrates that Auranofin can be oxidized
chemically and electrochemically at the thiolate center forming a disulfide and a

O ~ ) ~redox
.
behavior provides an
bridging thiolate cluster [ ( E ~ ~ P A u ) ~ ( T A T G ) ] ~ ( NSuch
insight into the possible biological reactions that occur upon administration of
Auranofin. The prediction of the fate of Auranofin in vivo is complicated by a variety of
reactions occurring at the gold center. In addition the circulating form may be different
from that of the initial drug.1,2,5,16
Toxicity of anti-rheumatoid arthritis drugs is believed to be due to the formation
of disulfides which lead to oxidative stress in the cell.'' The formation of disulfide and

cluster by mild oxidation of Auranofin is directly related to the oxidative stress effect.
One-electron oxidation of Auranofin results in homolytic cleavage of the Au-S
bond and formation of Et3PAu' and thiyl radical, SR, which rapidly dimerizes to
produce disulfide (see Scheme 3.2). Previous studies in our lab on the electronic
structure of gold@) thiolate complexes have assigned the HOMO orbitals of these
complexes as having significant sulfur character.l 9 The cation, Et3PAuf, reacts with a
molecule of the starting mononuclear complex to form a digold complex with thiolate
bridging two gold centers, which dimerizes via Au ...Au bonds to form the observed
tetragold cluster.
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LAuSR - e-

- - - -,

RS'

LAu+

____+

+ LAuSR

2 LAuSR

- e'

LAu'

+ RS'

%RSSR
b

b
-

% [L~AU~(P-SR)~]*+

% RSSR

+ '/t [L4Au4(p-SR)2I2+

Scheme 3.2. Mechanism of Auranofm oxidation (L = Et3P, R = Tetraacetylthioglucose).

The mechanism of Auranofin oxidation is supported by the independent
synthesis of the tetragold cluster (see Scheme 3.1) and is consistent with the n value

(0.5) determined by bulk electrolysis.
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CHAPTER 4

Electron-Transfer Studies between Ferrocene and Gold Thiolates.
Determination of the Standard Potential of Gold@) Thiolate Oxidation

Introduction

The medicinal effects of gold(1) thiolate drugs have been extensively investigated
during the last two decades.' Redox reactivity of gold(1) thiolate drugs, especially
oxidation, has been invoked in partial explanation of both therapeutic and toxic side
effects. Oxidation of Auranofin with hypochlorite, a strong oxidant released by
phagocytic cells, has also been studied by Shaw and coworkers. Sulfonate and Et3PO
formed first followed by oxidation of gold(1) and gold(III).'
The electrochemistry of a series of neutral phosphine gold(1) thiolate complexes
The series includes cyclic dinuclear gold(1)
has been investigated in our lab~ratory.~
complexes formed Gom 1,2-propanedithiolate (pdt) and bis-chelating phosphines,
Au2(LL)(pdt) (LL

=

dppe and dpppn), open dinuclear gold(1) complexes formed Gom

para-thiocresolate @-tc) and bis-chelating phosphines, AuZ(LL@-tc)*(LL

=

dppe, dppe,

dppp, dppb, or dpppn), and mononuclear complexes, Auranofin and Au(PPh3)b-tc).
Oxidative cyclic voltammetry experiments were performed at Pt and glassy carbon
or 0.1 M BqNBF4/CH2C12
electrodes in 0.1 M BQNPF~CH~CN

solution^.^

Cyclic voltammetry studies on PPh3Au(p-tc) showed two irreversible peaks at
+0.82 and +1 S O V vs. Ag/AgC1.4 However, Auranofin showed two irreversible peaks at
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higher potentials of +1.1 and +1.6 V vs. Ag/AgCI. The first irreversible peaks in
PPh3Au(SC6&CH3) and Auranofin were assigned as thiolate oxidation to the
corresponding di~ulfide.~
Our group has also studied the chemical oxidation of a series of mononuclear and
dinuclear gold(1) thiolates using [Cp#e]PF6 in CHzC12.’ The results of the oxidation
showed the formation of gold(1) clusters and disulfide. The chemical oxidation process is
complete within 2-24 hours. For example, PPh3AuQ-tc) is oxidized by [Cp#e]PF6 more
quickly than Auranofin. The simple explanation of this time variation is based on the
accessibility of the thiolate oxidation potential to Fc/Fcf couple.
Our goal of this study is to report the standard potential of the irreversible thiolate
oxidation in gold(1) thiolate complexes, such as PPh3AuQ-tc) using [Cp2Fe]PF6 and
cyclic voltammetry. Quantitative measurements of Cp2Fe and [Cp#e]PF6 will be
measured by using W - v i s spectroscopy.

Experimental Section
Reagents. Methylene chloride and acetonitrile were purchased from Aldrich. Supporting

electrolyte, tetra-N-butylammonium teterafluoroborate (BQNBF~)was purchased from
Aldrich and recrystallized (2X) from CH2Wether. Auranofin was purchased from
Pfanstiehl Laboratories, Inc. PPh3Aub-tc) was prepared according to previously
published methods. [Cp#e]PF6 and CpzFe were purchased from Aldrich; CpzFe was
purified by sublimation.
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Cyclic Voltammetry (CV) Experiments. CV experiments were conducted using an EG
& G Princeton Applied Research 273 potentiostat/gavonostat under computer control.

CV measurements were performed in CH2C12 or CH3CN with 0.15 M Bu4NBF4 as
supporting electrolyte using the same setup as shown in Figure 2.1. Cyclic
voltammograms were recorded in the potential range 0 to 1.9 V.
UV-vis Measurements. W-visible spectra were obtained by using a Hewlett Packard
8452 diode array spectrometer in I-cm quartz cuvettes.
Chemical Equilibrium Studies. All manipulations were carried out in the dry box.

Solutions containing the components were allowed to react in the dry box for 24, 48, and
72 hrs and samples were taken to check the completeness of the reaction by using UVvis. The quartz cuvettes for W - v i s measurements were sealed with rubber septa. The
reaction was found to be complete after the first 24 hrs. Chemical equilibrium constants
and standard oxidation potentials were calculated using equations shown in the results
section.

Results and Discussion.

Recently, we reported on the electrochemical and chemical oxidation of gold
thiolates such as PPh3Au(SC&CH3)

and A ~ r a n o f i n .Electrochemical
~
oxidation of

Auranofin in 0.1 M BaNBF4/CH2C12 showed two irreversible peaks at +1.1 and +1.6 V
vs. Ag/AgCl. The first irreversible oxidation potential at +l. 1 V was assigned as thiolate
oxidation to disulfide based on bulk electrolysis studies. The chemical oxidation of
gold(1) thiolates, using [Cp2Fe]PF6, formed a tetragold(1) cluster and di~ulfide.~
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Our goal is to measure the standard potential of gold(1) thiolate oxidation by using
a reversible couple such as Fc/Fc+. The oxidation of gold(1) thiolates using [Cp2Fe]PF6 in
acetonitrile under nitrogen produced disulfide, cluster, and ferrocene. The cluster was
formed by dimerization of the first formed dinuclear species to form a tetranuclear
gold(1) cluster.

Electrochemical Studies.
The cyclic voltammetry of a 10 mM solution of Cp2Fe in 0.15 M
BW&BF~/CH~CN
solution at a scan rate of 100 m V i ' in the potential range 0 to 0.75 V is
shown in Figure 4.1. The reversible couple for 10 mM Fc/Fc+ is seen at El/*= 0.50 V;
however the thiolate oxidation of a 10 mM solution of PPh3Au(SC&CH3) obtained at
0.9 V vs. AglAgCl. A mixture of 10 mM Cp2Fe and 10 mM PPh3Au(SC6&CH3) showed
an enhancement in current under the ferrocene peak. The enhancement in current showed
that ferrocene is an electron-transfer c a t a l y ~ t . ~ ' ~

UV-vis studies. Reaction of PPh3Au(SC&CH3)

with [CpzFe3' in acetonitrile was

followed by UV-vis for several days (Equations 4.1 and 4.2). The peaks at 440 nm
98) and 630 nm

(E =

(E =

395) for ferrocene and ferrocenium, respectively, were monitored

for 3 days and the reaction was found to be complete in the first 24 hrs. Figure 4.2 shows
the W - v i s spectra of -5.12 mM [Cp2Fe]PF6 in CH3CN and its UV-vis spectrum after
reaction with -10 mM PPh3Au(C&CH3) after equilibration. The quantities of [Cp2Fe]
and [CpzFe]+at equilibrium were measured by Beer's law plots for each compound

-

v

\
PPh3AuSC6H,CH3(10 mM)

Ferrocene (10 mM)

Ferrocene (10 mM) + PPh3AuSC6H,CH3(10 mM)

2

1.8

1.6

1.4

1.2

1

0.8

0.6

0.4

0.2

E vs. Ag/AgCl
Figure 4.1. Cyclic voltammetry of ferrocene (10 mM), PPh3Au(SC6H4CH3)(10 mM), and their mixture (10

mM) in 0.15 M Bu4NE3F4/CH3CNusing Pt working electrode.
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(Figure 4.3 and 4.4). Reduction of [Cp2Fe]' to [CpzFe] referencing was 86% complete in
the first 24 hrs. At 86% of the reaction completion, the equilibrium constant (Equations
4.3, 4.4, and 4.5), Keq, was found to be 14.54 x

M-'. Figure 4.5 shows the effect of

completion of the first reaction (Equations 4.1 and 4.2), i.e. Fc'/Fc, on the standard
potential of gold thiolate. In a broad sense, the standard potential decreases as the
reaction goes to completion. From Figure 4.5, at 86% completion of the Fc'/Fc process
the standard potential of thiolate oxidation is 0.25 V vs. Ag/AgCl; at 40% completion the
potential is 0.37 V (Equation 4.6).

PPh3AuSR + Fc+

=

PPh3AuSR' + Cp2Fe

4.1

PPh3AuSR+ + PPh3AuSR

=

[ ( P P ~ ~ A u ) ~ ( S R+)[RSSR]lD
~]~/~

4.2

K1= [PPh3AuSR]+[Cp2Fe]/[PPh3AuSR] [Cp2Fe]+

4.3

K2 = [(PPh3Au)4(SR)2]'"[RS SR]'n/[PPh3A~SR]+[PPh3A~SR]

4.4

Keq = K1 .K2 = [(PPh~Au)~(SR)2]''2[RSSR]"2[Cp2Fe]/[Cp~Fe]+[PPh~AuSR]2

4.5

The symbol E represents the potential and Eo(Fc/Fc+) is a constant (0.35 V), called the
standard potential. The gas constant R is expressed in joules K'' mol-', T is the
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temperature (in kelvin); n is the number of electrons appearing in the balanced equation
for the half-reaction, and F is the number of coulombs per mole (965,485 coulombs).6

=E ' I I ~ ~ ~/ FRTInF
~ + ) log

[Cp2Fe]/[Cp2Fe]+

4.6
E'I/Z(A~/A~+)
- E ' I / ~ ~ ~ =/ F0.059
~ + ) l/n log [ P P ~ ~ A u S R
[Cp2Fe]+/[PPh3AuSR]+[Cp2Fe]
]

Where n = 1 and E'~,Z(F~/F~+)
= 0.35 V
[PPh3AuSR] = [Cp2Fe]+
[PPh3AuSR]+= [Cp2Fe]

As shown in Equation 4.2, one molecule of PPh3Au(SC&CH3)

is depleted by

reaction with another molecule of PPh3Au(SC&CH3)+ to form a gold(1) cluster and
disulfide. Figure 4.6 shows the effect of [PPh3Au(SC6&CH3)] or [PPh3Au(SC&CH3)]+
depletion on the standard potential of gold(1) thiolate oxidation. As expected, as the
species is depleted the standard potential decreases gradually. Assuming the chemical
reaction in Equation 4.2 is not considered, the standard potential would be 0.25 V vs.
Ag/AgCl (Figure 4.6).
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Conclusion

The irreversible oxidation of gold(1) thiolates was explained by an EC
mechanism, i.e. thiolate oxidation followed by formation of disulfide. The standard
potential of thiolate oxidation was determined using the reversible couple Fc/Fc+. The
standard potential of the gold(1) thiolate complex, P P ~ ~ A u ( S C ~ & C H
was
~ ) ,estimated,
based on simulation, to be 0.25 V vs. Ag/AgCl. Ferrocene, an electron-transfer catalyst,
enhances the current of the thiolate oxidation.
Further estimation of the potential may be found by trying other oxidants that
have potentials more positive than [Cp2Fe]PF6 such as [Cp*2Fe]PF6.
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CHAPTER 5

Oxidation Chemistry of Solganol: Anti-Arthritic Gold-Sulfur Drug

Introduction
That gold complexes are effective as anti-rheumatoid arthritis is well
documented.' Gold(1) thiolates, administered parenterally (by injection), have been used
for many years in the treatment of rheumatoid arthritis. Solganol (Figure 5.1), a water
soluble but not lipid soluble gold(1)-thioglucose drug, has been used for the treatment of
rheumatoid arthritis for over half a century.'

OH

n

Solganol

Figure 5.1. Structure of Solganol.
While there is no available x-ray crystal structure for Solganol; recently Bau
reported the x-ray crystal structure of Myochrysine, gold(1)-thiomalate, as a polymeric
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structure with two interpenetrating spirals.' The unit cell contains two independent gold
atoms, one of which has an essentially linear S-Au-S arrangement ( I 78.9') and the other
is distorted from linearity to 169.4.2
The polymeric yellow solution of Solganol is characterized by two broad bands in
the UV-vis spectrum; the first band occurs at 250 nm and the second at 270 nm with a tail
beyond 400 n ~ n The
. ~ 1 9 7 AMossbauer
~
spectroscopy shows gold atoms coordinated to
two thioglucose units (IS = 1.40, QS

=

6.20 mm s-I) and extensive polymerization is

po~sible.~
The chemical oxidation of Solganol in aqueous medium occurs upon addition of
hypochlorite, a strong oxidant released by phagocytic cells5 The oxidation process
involved thioglucose ligand followed by Au'/"' oxidation. The oxidation to Au(II1) was
confirmed by UV-vis and Ion-Chromatography after treating the oxidation product with
HC1. Hypochlorite oxidation of Solganol occurred slightly slower than for Myochrysine
(gold(1)-thiomalate) near the end point5 Aqueous solutions of Solganol undergo redox
reactions to form Au(0) and the disulfide, TgSSTg, which subsequently undergoes
hydrolytic redox disproportionation to TgSOzH and TgSH.6

2H20 + 4AuSTg

b
-.

4Auo + TgS02H + 3TgSH

5.1

While there is great interest in the biological study of gold drugs; little is known
about their redox behavior.' Studying the redox behavior of gold(1)-drugs is directly
related to their toxicity and therapeutic effects in vivo. As an extension of our work on the
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chemical and electrochemical oxidation of gold(1)-drugs we decided to investigate the
oxidation of Solganol, in aqueous medium, using cyclic voltammetry and the chemical
oxidizing agent such as [Cp#e]PF6.

Experimental Section
Reagents. Water, D20, HCl, [Cp2Fe]PF6, and sodium perchlorate (NaC104) were

purchased from Aldrich and were used as received. Solganol was purchased from Fluka
and was used as received.
Cyclic Voltammetry (CV) Experiments. CV experiments were performed using an
EG&G Princeton AppIied Research 273 potentiostatlgalvanostat under computer control.

CV measurements were performed in 0.5 M NaC104/H20 using the same setup shown in
Figure 2.1. Cyclic voltammograms were recorded in the potential range 0 to 1.7 V in H2O
under nitrogen with 0.5 M NaC104 as supporting electrolyte. All potentials were referred
to a silver-silver chloride electrode (Ag/AgCl) at room temperature. pH values were
adjusted by Analar grade HCl.
Bulk Electrolysis. Bulk electrolysis experiments were performed as described in chapter

2 and Figure 2.2. The electrolytic cell was assembled after oven drying at 110' C. A 0.5

M NaC104/H20 solution was introduced into the cell, stirred, and degassed with nitrogen
for 10 minutes. Solganol was added (10 to 20 mg) and the solution was stirred for 10
minutes. The total number of electron equivalencies (n) and coulombs (Q) passed were
calculated as shown in chapter 2.
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H N M R measurements. 'H NMR spectra, recorded in D20, by using a Gemini 300

N M R spectrometer. Chemical shifts were measured relative to the HDO resonance.
Chemical Oxidation. To 7.0 mg (1 mmol) of Solganol dissolved in 5 ml DzO was added
3 mg (0.5 mmol) of finely grounded [Cp#e]PF6. The mixture was stirred and a sample

was taken after 24 hr for 'H NMR. The yellowish-green color due to [Cp#e]PF6 did not
change even after 72 hrs of mixing.

Results and Discussion

Cyclic voltammograms of degassed 6 mM Solganol were investigated in 0.5 M
NaC104/H20 solutions at a Pt wire counter electrode, an Ag/AgCl reference electrode,
and a Pt working electrode. Solganol solutions showed a well-defined irreversible
oxidation peak at +1.2 V vs. Ag/AgCl dependent of the scan rate, concentration, and pH
values. The oxidative response of Solganol solutions investigated in the potential range 0
to +1.7 V is irreversible even at slow scan rates of 20-100 mV/s.
The oxidative cyclic voltammogram of degassed 6 mM Solganol at 20, 50, and
100 mV/s is shown in Figure 5.2. The position of the peak shifted to higher potentials
with increasing scan rate from 20 to 100 mV/s. At higher scan rates (>lo0 mV/s) a
reduction peak at +0.5 V (return scan) started to grow in and the peak at +1.2 V increased
in current (see Figure 5.3).
Multiple scan cyclic voltammograms obtained for degassed 6 mM Solganol in the
potential range 0 to +1.5 V and at a scan rate of 100 mV/s are shown in Figure 5.4, the
first and fifth scans are shown only in the figure. The first scan was taken after cleaning
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the electrode while the other scans were taken continuously. The feature of the slightly
asymmetric broad peak at +1.2 V changed to a symmetrical sharp response by the fifth
cycle. This behavior is due to a possible filming of the redox products on the electrode.
The newly formed peak at +0.2 V assigned to the reduction of the hydrolyzed Au(II1)
formed after the oxidation of Au(I).'

pH Studies. The pH dependence of the cyclic voltammograms of 6 M Solganol was
studied by gradually decreasing the pH by the stepwise addition of HCl. Solganol showed
similar cyclic voltammetry behavior, i.e. no additional peaks, at different pH values by
using HC1 (Figure 5.5). Generally, the redox peaks shifted to lower potentials upon
lowering the pH values.
Electrochemical reduction of 6 mM HAuC14 in 0.5 M NaC104/H20 at a scan rate
of 100 mV/s is shown in Figure 5 . 5 ~ The
.
reduction peak at 0.55 V is coupled with an
oxidation peak at 1.10 V vs. Ag/AgCl. The reduction of HAuC14 at 0.55 V is due to the
AuCl4-/AuCl2-process and the peak at 1.10 originates from the oxidation of the generated
AuC1; to Au(III)?
At pH

=

2, 6 mM Solganol solution showed an oxidation peak at 1.18 V vs.

Ag/AgCl (compare Figure 5.5a vs. 5.5b). At this low pH value Solganol is expected to
transform to AuC1; which in turn oxidizes to Au"' at 1.18 V.

Bulk Electrolysis and Chemical Oxidation. Bulk electrolysis of Solganol at +1.3 V vs.
AglAgC1 in 0.5 M NaC104/H20 showed that n
Au'"'

=

2 (2.2, 2.1, and 1.8), consistent with a

oxidation. Bulk electrolysis of Auranofin at +1 V vs. Ag/AgCl in 0.1 M
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BU&BF~/CH~C~~
showed that the oxidation is a 0.5 electron process, i.e. sulfur-based
oxidation.

''

Chemical oxidation using [Cp2Fe]PF6 in D20 was followed by 'H NMR. The
characteristic peaks of the thioglucose unit did not shift and the characteristic color of
[Cp#e]PF6 persisted in the solution. This shows the high stability of the thiolate in the
polymeric Solganol to oxidation. Oxidation of Auranofin using [Cp#e]PF6 resulted in
formation of disulfide and tetragold(1) cluster (chapter 3).

Conclusion
Previously,

we

reported

on

the

oxidative

cyclic

voltammetry

of

Auranofin, 2,3,4,6-tetra-0-~-D-glucopyranosato-S(triethylphosphine)gold
(I), in 0.1 M
B Q N P F ~ C H ~or
C~
0.1
~ M Bu&BF4/CH2C12 solutions at a Pt working electrode vs. a
Ag/AgCl reference electrode, Table 5.1.'' Two irreversible anodic peaks at +l.l and +1.6

V vs. Ag/AgCl were obtained and assigned as thiolate and Au(I) responses,
respectively."
Anderson and Sawtelle have investigated the aqueous redox processes for the
electrogenerated gold(1) species, [AuC12]-, complexed by biologically relevant ligands
such as cysteine and penicillamine.' They propose an aqueous reduction mechanism that
begins with [AuC14]- as illustrated in equations 5.2-5.4. The progress of these electron
transfer and coupled chemical reactions can be followed by cyclic voltammetry and UVvis spectroelectrochemistry. Upon formation of [AuClJ,

addition of cysteine or

penicllamine leads to complexation and changes in the electrochemistry, which allows an
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estimation of the oxidation potentials (see Table 5.1) of the Au[cysteine] and
Au[penicillamine] complexes. Cyclic voltammetry control experiments with cysteine and
penicillamine indicate that the observed electrochemical responses do not originate from
these free species in solution (see Table 5.1).9

[AuCldI-

=

[AuC12]+ + 2 C1-

5.2

[AuC12]+ + 2 e-

=

[AuC12]-

5.3

[AuC12]- + e-

-

Au

+

2C1-

5.4

Comparing the oxidative study of Auranofin vs. Solganol, the former studied in a
non-aqueous medium (CH2C1,) and showed two anodic peaks at 1.1 V (sulfur based
oxidation) and 1.6 V (gold based oxidation) vs. Ag/AgCl while the latter showed only
one anodic response at 1.2 V vs. Ag/AgCl. The second anodic peak (irreversible) in
Auranofin at 1.6 V which was assigned as gold based-oxidation ( A U ~ " )corresponds to
the oxidation peak at 1.2 V in Solganol.
Recent results fiom our laboratory indicate that mononuclear and binuclear
phophine gold(1) thiolate complexes undergo one-electron oxidation to form tetranuclear
gold(1) clusters and disulfide." Our study proved that Solganol behaved differently from
other complexes, perhaps due in part to the polymeric nature of Solganol. Cyclic
voltammetry of linear phosphine gold(1) thiolate complexes showed an irreversible
sulfur-based oxidation process above +0.5 V (vs SCE); however, magnesium complex
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with bridging thiolates, Mg(Py)3(p-SPh)3-Mg(pSPh)3Mg(Py)3, shows only an irreversible
oxidation at +0.975 mV (vs SCE).'*

To summarize, the irreversible peak at +1.2 V vs. Ag/AgC1 was assigned as Aum'
based on the following facts:
1. Bulk electrolysis at +1.3 V showed n = 2.
2. Chemical oxidation of Solganol showed no change in the 'H N M R or the color

of FcPF6, which indicates no thiolate oxidation.
3 . At pH = 2 (HCl), the oxidation peak for a Solganol solution is similar to the
reduced form of HAuC14, i.e. AuClY.
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CHAPTER 6

Synthesis, Characterization, and Photophysical Studies of Dinuclear Gold (
I
Halide
)
and Thiolate Complexes of Bis(dipheny1phosphine)benzene. X-ray

Crystal

Structure of (AuC1)zdppbz

Introduction

Phosphine gold (I) thiolates have a long history of medicinal activity as antirheumaoid arthritis drugs. Auranofin, 2,3,4,6-tetra-O-acetyl- 1-P-D-glucopyranosatoS)(triethylphosphine) gold(I) is an orally effective antiarthritic agent in experimental
animals and men. A number of dinuclear phosphine gold(1) thiolates have been evaluated
for antitumor activity.’,’
The antitumor activity of phosphine ligands has been reported after isoIating

bis(diphenylphosphine)ethane,

dppe, as

a

by-product fiom the

synthesis

of

Ph2P(CH2)2Cl.’ Complexation of the phosphine ligands as dppe with gold(1) protects the
ligand fiom air oxidation and increase its cytotoxicity which is evident in the
(AuC1)zdppe with more cytotoxicty than dppe alone.’ Bisphosphines e.g. R2P(CH2),,PR2
(n

=

1-4, R

=

Ph or Et) and Ph’PCH=CHPPh2 have been shown to posses a broad

spectrum of antitumor effects in p3 88 leukemia models2 Linear digold(1) bisphosphine
molecules are the subjects of many clinical studies in order to establish their promised
antitumor activity.’ Our group has been investigating dinuclear gold(I) complexes such as
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Au~(P-SC~H&H~)~(LL)
and Au~(SCH~CH~CH~S)(LL)
where LL is a flexible,
bisphosphine

ligand

varying

from

1,l -bis(diphenylphosphino)methane

to

1,5-

bi~(dipheny1phosphino)pentane.~These complexes exhibit S -b Au charge transfer
transitions in the UV-visible (330-360 nm) that appear to be perturbed by gold(1)-gold(1)

interaction^.^^

Recently our group investigated the dinuclear, gold(1) complexes

employing cis- and trans-dppee ligands, Au2Xz(cis-dppee) and AuzX2(trans-dppee) (X =
C1, Br, I, p-SC6H&H3).4 These two series offer the opportunity to examine and compare
electronic structure and reactivity of conformations in which the two gold atoms are
constrained to be within bonding distance vs. where intramolecular approach of the two
gold atoms is precluded.

Ph

\

/Ph
p\
"\/
Au\X
'

I

Ph

hv

II

II

A

\

/Ph
p
,

H\C/
It

B
X = CI, Br, I, P S C G H ~ C H ~

AU\)(
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In this study the backbone is the phenyl ring in bis(dipheny1phosphine)benzene is
more rigid than the ethylene group in bis(dipheny1phosphine)ethylene. Hence the cis-trans
isomerization is precluded. Our goal is the synthesis, characterization, and investigation
of the photophysical behavior of a new class of halo and thiolato gold (I) complexes of
the formula (AuX)zdppbz, X

=

C1, Br, I, p-SC6KCH3. The x-ray of (AuC1)2dppbz as an

example of the linear geometry of the dinuclear gold(1) complexes will be discussed.

Ph

\ /

Ph

X = CI, Br, I, p-tc
Experimental Section
Reagents. Solvents were purchased from Aldrich and used as received without further

purification. HAuC14.3H20 was purchased from Aithaca or was obtained as a loan from
Alfa Aesar/Johnson Matthey.. The ligand dppbz, HAuBr4.3H20, Et4NBr, EGNI, and p thiocresol were purchased from Aldrich.
Measurements. Microanalyses were performed by Dessert Analytics, Az. Melting points

were determined by using a Thomas Hoover melting point apparatus and reported without
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correction. 'H NMR spectra, recorded in CDC13 or CD2C12, by using a Gemini 300 N M R
spectrometer. Chemical shifts were measured relative to the solvent re~onance.~'P
NMR
resonances were recorded in CDC13 and referenced to an external sample of 85% H3P04.
Luminescence experiments were made by using a Perkin-Elmer LS-50 Luminescence
Spectrometer. A 40-50 p time delay between excitation pulse and emission detection
was used to eliminate light scattering and to observe phosphorescence. Slit widths for
excitation and emission monochromators were typically set at 10 nm. UV-visible spectra
were obtained using a Hewlett Packard 8452 diode array spectrometer in 1 cm quartz
cuvettes.
Synthesis of [p-1,2-Bis(diphenylphosphino)benzene]bis[Chlorogold(I)] (1). In a round

bottomed flask, thiodiethanol (0.45 ml, 2.22 mmol) in MeOH (3 ml) was added over 15
min to a solution of HAuC14.3H20 (0.40 g, 1.1 1 mmol) in H20 ( 5 ml)/MeOH (8 ml) kept
at 0 'C. After stirring for an additional 15 min, dppbz (0.25 g, 0.56 mmol) in a mixture of
CHC13 (15 ml)/MeOH (10 ml) was added to the colorless gold solution yielding an
immediate white precipitate. The mixture was warmed to room temperature (1h) and
MeOH (30 ml) was added to enhance the formation of precipitate. The white precipitate
was filtered after stirring for additional 1h and washed with MeOH and air dried to give
0.38 g. Recrystallization of the white powder from CH2C12Et20 gave 0.25 g. Crystals for

x-ray analysis were grown by a slow diffusion in methylene dichlorideEt20.
Synthesis of [~-1,2-Bis(diphenylphosphino)benzene]bis[Bromogold(I)] (2). Method

A. To 0.25 g of 1 in a round-bottomed flask, dissolved in 15 ml CH2C12, was added
slowly 0.28 g of BWNBr, dissolved in 5 ml CH2C12, and the solution mixture was stirred
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for 15 min. A cloudy white precipitate formed and stirring continued for 30 min. The
solvent was reduced in vucuo to 5 ml. Excess methanol (20-30 ml) was added to facilitate
the precipitation process. The white precipitate was filtered, recrystallized from
CH2C12Et20, and air-dried to yield 0.26 g. Method B. In a round bottomed flask,
thiodiethanol (0.50 ml, 5.0 mmol) in MeOH (3 ml) was added over 15 rnin to a solution
of HAuBr4.2H20 (0.50 g, 0.84 m o l ) in H20 ( 5 ml)/MeOH (8 ml) kept at 0 'C. After
stirring for an additional 15 min, dppbz (0.166 g, 0.37 mmol) in CHC13 (15 ml)/MeOH
(10 ml) was added to the colorless gold solution yielding an immediate white precipitate.
The mixture was warmed to the room temperature (lh) and MeOH (30 ml) was added to
complete the precipitation process. The white precipitate was filtered after stirring for an
additional lh, washed with MeOH, and air dried to give 0.25 g. Recrystallization of the
white powder from CHzClzIether gave 0.20 g.
Synthesis of [~-1,2-Bis(diphenylphosphino)benzene]bis[Iodogold (I)] (3). The same

procedure was used as for 2, method A. Using BmNI as the source of iodide. The sample
was recrystallized from CH2C12Et20 to form an off-white solid.
Synthesis of [pL-1,2-Bis(diphenylphosphino)benzene]bis[p-thiocresolatogold (I)] (4).

0.05 g (0.05 m o l ) of 1 was dissolved in 7 ml of CH2C12. 0.02 g (0.10 mmol) p thiocresol was dissolved in 5 ml ethanol. 25 ml of 0.1 M NaOH was added slowly and the
solution was stirred for 30 min. The thiolate solution was slowly added to the methylene
dichloride solution of 1 and a yellow color formed immediately. Stirring was continued
for 30 min and a yellow precipitate formed gradually. The volume was reduced to 5 ml in
V ~ C U Oand

more precipitate formed. The yellow precipitate was filtered and washed with
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hexanes and ethanol. In order to get rid from the tetrahedral structure which formed I did
the solvent extraction by water of (Au-p-tc)2dppbz solution in methylene dichloride. The
product was recrystallized from CH2C12hexanes to yield 0.021 g.' Table 6.1 shows the
characterization data for (AuX)zdppbz, X

=

C1, Br, I, andp-CH&&S.

Figures 6.1, 6.2,

and 6.3 show 'H N M R of dppbz ligand and its complexes.
Abbreviations: The following abbreviations are used: p-tc

propanedithiol;

dppe

=

p-thiocresol; pdt

1,2-bis(diphenylphosphine)ethane;

bis(dipheny1phosphine)propane; dppb
bis(dipheny1phosphine)pentane.

=

=

dppp

=

1,2-

=

1,2-bis(diphenyIphosphine)butane; dpppn

1,3-

=

1,2-

Figure 6.1.‘H NMR spectrum in CDCl3 of bis(dipheny1phosphino)benzene.

133

P

P

1

c

134

I

135

Crystal Structure Analysis of [pL-l,2Bis(diphenylphosphino)benzene]
bis[Chlorogold(I)](l). Crystals of (AuC1)2dppbz were obtained as colorless needles from
CH2C12-Et20. Crystal data, data collection and processing parameters are reported in
Table 6.2. Selected bond lengths and angles are listed in Table 6.3. Atomic coordinates [x
104] and equivalent isotropic displacement parameters

[A2 x

lo3] for (AuC1)zdppbz are

given in Table 6.4. For x-ray examination and data collection, a suitable crystal,
approximate dimensions 0.45 x 0.12 x 0.08 mm, was mounted on the tip of a glass fiber.
X-ray data was carried out by Dr. J. Krause Bauer, Department of Chemistry, University
of Cincinnati. Intensity data were collected at 293K on a Siemens SMART 1K CCD
diffractometer (platform goniostat with x fixed at 54.69', sealed-tube generator, graphitemonochromated Mo k a radiation, h

=

0.71073

A). The structure was solved by a

combination of the Patterson method using SHELXTL v5.1 and the difference Fourier
technique and refined by full-matrix least squares on F2 for the reflections diffracting out
to 0.75

A. Non-hydrogen atoms were refined with anisotropic displacement parameters.

Weights were assigned as w-'
0.33333Ft + 0.66667F;.

= o2( F t )

+ (ap)2 + bp where a = 0.0299, b = 0.000 and p =

Hydrogen atoms were calculated based on geometric criteria

and treated with a riding model. Hydrogen atom isotropic temperature factors were
defined as U(C)*a = U(H) where a = 1.5 for methyls and 1.2 for aromatics. (AuC1)zdppbz
crystallizes with a badly disordered solvent which appears to be EtzO. A suitable disorder
model could not be resolved, thus the solvent contribution was subtracted from the
reflection data using the program SQUEEZE. The refinement converged with
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crystallographic agreement factors of R1

=

4.29 %, wR

=

6.60 % for 5769 reflections

with I 2 2 0 (I) (R1 = 8.86 %, wR2 7.64 % for all data) and 325 variable parameters.

137

Table 6.2. Crystal data and structure refinement for (AuC1)zdppbz (1)

Empirical formula

C30H24AU2C12P2

Formula weight

911.27

Temperature

293(2) K

Wavelength

0.71073 A'

Crystal system, Space group

Orthorombic, Pbca

Unit cell dimensions

a = 16.955(3)&
b = 18.160(2)A,
c = 22.225( 1)A

Volume, Z

6843.7(2) A3, 8

Density(calcu1a ted)

1.769 Mg/m3

Absorption coefficient

8.830 mm-'

F(000)

3408

Crystal size

0.45 x 0.12 x 0.08 mm

8 range for data collection

2.40 to 28.30

Limiting indices

- 18<h<22,-23<k<24,-29<1<24

Reflections collected

45724

Independent reflections

8478 (Rint

Max. and min. transmission

0.5385 and 0.1093

Refinement method

Full-matrix least-squares on F2

Data/restraints / parameters

8478 I 0 I325

Goodness-of-fit on F2

1.048

Final R indices [1>20(1)]

R1 = 0.0429, wr2 = 0.0660

R indices (all data)

R1 = 0.0886, wR2 = 0.0764

Largest diff. Peak and hole

0.573 and -0.576 eA-3

'

= 0.0605)
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Table 6.3. Selected bond lengths (A) and angles (O) for (AuC1)2dppbz (1)
Au( 1)-P(1)

2.24 l(2)

Au( l)-C1( 1)

2.292(2)

Au( l)-Au(2)

2.996( 1)

Au(2)-P(2)

2.236(2)

Au(2)-C1(2)

2.2 93(2)

P(1)-C(7)

1.807(6)

P(1)-C(l)

1.8 17(6)

P(1)-C( 13)

1.837(6)

P(2)-C( 19)

1.821(6)

P(2)-C( 14)

1.824(6)

P(2)-C(25)

1.828(6)

C(13)-C (14)

1.415 (8)

P( l)-Au( l)-C1( 1)

173.07(6)

P(l)-Au( l)-Au(2)

79.63(4)

C1(l)-Au( l)-Au(2)

102.99(5)

P(2)-A~(2)-C1(2)

173.2(6)

P ( ~ ) - A u ( ~ ) - A 1)
u(

95.7 l(4)

C ~ ( ~ ) - A U ( ~ ) -1)
A U ( 91.06(5)

C(7)-P( 1)-C( 1)

104.1(3)

C(7)-P( 1)-c(13)

107.1(3)

C( 1)-P(1)-C( 13)

106.0(3)

C(7)-P(l)-Au( 1)

116.8(2)

C (1)-P( 1)-Au( 1)

113.6(2)

C( 13)-P(l)-Au(l)

108.6(2)

C(19)-P(2)-C(14)

104. 8(3)

C (19)-P(2)-c(25)

106.4(3)

C(14)-P(2)-c(25)

103.7(3)

C(19)-P(2)-A~(2)

1 10.6(2)

C( 14)-P(2)-Au(2)

120.2(2)

C(25)-P(2)-Au(2)

1 10.2(2)

C(14)-C( 13)-P( 1)

123.4(4)

C(13)-C(14)-P(2)

127.3(4)
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Table 6.4. Atomic coordinates [x 104] and equivalent isotropic displacement
parameters

C(30)

[A2 x 103] for (AuC1)2dppbz (1).
X

Y

z

U(eq>

1358(1)
2894( 1)
996( 1)
3465( 1)
1589(1)
2474(1)
1029(3)
304(4)
- 127(4)
160(5)
874(5)
1297(4)
2596(3)
2947(4)
3722(4)
4154(4)
3837(4)
3060(4)
1280(3)
1609(3)
1266(4)
645(4)
340(4)
652(4)
325 2(4)
4007(4)
4635(4)
4508(4)
375 7
( 4)
3122(4)
2224(3)
2502(4)
2272(5)
1781(5)
1513(5)
i734(4)

8185( 1)
8904( 1)
7635(1)
7780( 1)
8815(1)
10059( 1)
848l(3)
8 14l(3)
7869(4)
7920(4)
8259(5)
8536(4)
8836(3)
9461(4)
9472(5)
8835(6)
8 198(5)
8 190(4)
9774(3)
10240(3)
10934(3)
1 1 189(3)
10729(4)
10030(3)
10625(3)
1054l(4)
1094l(4)
11412(4)
1 1505(4)
11 124(3)
10478(3)
1 1 160(4)
11460(4)
11079(5)
10399(6)
1008 3(4)

4859(1)
4549( 1)
3973(1)
4370(1)
5708( 1)
4686( 1)
6350(2)
6259(3)
672l(3)
7298(3)
7405(3)
6925(3)
5974(3)
6204(3)
6377(3)
6329(3)
6115(3)
5932
( 3)
5595(2)
5 150(3)
5069(3)
5415(3)
5846(3)
5935( 3)
5012(2)
4790(3)
503l(3)
5488(3)
5720(3)
5471(3)
3963(3)
3797(3)
3256(3)
2884(3)
3041(4)
3578(3)

4 w
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Results and Discussion

The reaction of [AuCl (thiodiethanol)], generated in situ by reduction of HAuC14
with thiodiethanol, with dppbz (2: 1) leads to a linear two-coordination complex,
(AuC1)zdppbz (1). Reacting 1 with Et4NBr or Et4NI leads to the formation of
(AuX);?dppbz,X

=

Br (2), or I (3), respectively. The thiolato derivative, 4 is obtained by

reacting 1 with deprotonated p-thiocresol. The thiolato substituent is prepared in situ by
deprotonation of p-thiocresol with an ethanol solution of NaOH. Isolated products were
assigned on the basis of N M R spectroscopy and analytical data (Table 6.1).
The 'H N M R of dppbz in CDC13 shows a complex multiplet at 7.0-7.4 pprn
(Figure 6.1). Coordination to gold derivatives shifts the peaks slightly downfield to 7.17-

7.6 pprn with a noticeable splitting in the peaks (Figure 6.2-6.4). A singlet resonance is
observed in all complexes in the 31P{'H} NMR study, which indicates the presence of
two equivalent phosphorous atoms at room temperature. The resonance of the free ligand
is recorded at -13.0 ppm and a downfield shift is observed upon coordination to gold(1).
The chemical shift of 30.8 ppm for 4 is characteristic of phosphine gold t h i ~ l a t e s . ~ ~

Molecular Structure of (AuC1)zdppbz (1). The molecular structure of (AuC1)2dppbz (1)

is shown in Figure 6.4; bond lengths and bond angles are reported in Table 6.3. The AuAu distance of 3.0(1)A is comparable to those observed for Aw(tppb)(C=CPh)4, tppb
tetraphenylphosphinobenzene

=

c4

Figure 6.4. Thermal probability ellipsoids of (AuC1)zdppbz.
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3.1541(4)A,' A u ~ ( ~ - S ~ C ~ B , O H , O ) 3.0746(9)
(PP~~)~,
3.0195(5)

A,8 and

Au~(~-L-S~C~BIOHIO)(~-L-~PP~

Au2(pS2C2BloHlo)(pL-dppph),2.9771( 10) A.7 The P-Au-Cl moieties

are linear (-1 73') with a dihedral angle of 105.9'.
(AuC1)2dppbz crystallizes in S-shaped layers with what appears to be badly distorted
Et20 solvent molecules. The solvent resides in the channels created by the S-shaped
nature of the layers. Since the identity of the solvent is not exactly known, the
crystallographic refinement was completed with the solvent contribution subtracted from
the data.
The bond lengths of Au-Cl and Au-P, bond angle of P-Au-Cl, and Au.. .Au distance in
(AuC1)2dppbz (l),a benzene-bridged complex, are of similar values to cis-(AuC1)2dppee,
an ethylene-bridged c ~ r n p l e x .In
~ cis-(AuC1)2dppee, the Au-P and Au-C1 lengths are
2.239(5) and 2.299(5)

A, respectively, which are similar to those of 2.236(2) and

2.293(2) in 1. The P-Au-C1 angle in 1 of 173.21' is comparable to 173.2' in cis(AuC1)zdppee. The gold-gold interaction did not change greatly by replacing ethylene by
phenyl; in cis-(AuC1)2dppee the Au.. .Au distance is 3.05 A, which is slightly greater than
that in 1 3.0 A.

UV-vis and Photophysical Studies. The W - v i s spectra of (AuX)zdppbz, X= Cl, Br, I,
p-tc in methylene chloride at room temperature all show a broad UV absorption band

(Ima
= 280 nm) that tails into the near visible. The UV-vis spectra for 1-4 in Figure 6.5
show a red shift in the onset of the manifold of low energy transitions going from X = C1
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to X = SR, which correlates to the softness of X. This trend indicates a significant
contribution of the ligand, X in the lowest energy transitions.
Luminescence studies on (AuX)zdppbz in degassed methylene chloride at room
and low temperatures resulted in peaks indistinguishable from the solvent. Similar results
were obtained for (AuX)2dppee under the same

condition^.^
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1. INTRODUCTION

Gold and silver belong to the group known as coinage metals. They occupy positions near
the bottom of the electrochemical series and so they are difficult to oxidize. Silver'oxidizes
to Ag+ at +0.7996 V vs NHE while Auo + Au' oxidation takes place at +1.692 V and
Au' -+ Au"' occurs at +1.498 V (Table 1). In contrast, metals near the top of the electrochemical series, such as Na, are very active, i.e. Na oxidizes to Na+ at -2.71 V vs NHE'.
The reactivity of Cu, Ag and Au decreases down the group2. Although gold and silver are
often grouped together, their chemical and physical properties differ significantly, partly
as a result of increased relativistic effects for gold3. The effects of solvent interaction
The chemistry of organic derivatives of gold and silver
Edited by S . Patai and Z. Rappoport 0 1999 John Wiley & Sons Ltd
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TABLE 1.

Standard reduction potentials of gold and silver compounds'

I?, V

Reaction

+
+
+
+
+
+
+
+
+
+
+
+
+
+

e-

=

2e-

=

e-

=

e-

=

e-

=

e-

=

+
+
+
+
+

+

YS

1-

-0.15224

co3z-

-0.017

Br-

t0.07133

c1-

t0.22233

NOz-

t0.564
t0.779
t0.7996
t0.854
t0.959
1.002
1- I .40i

F-

e-

=

3e-

=

e3e-

=
=

2e-

=

3e-

=

+1.498

e-

=

t 1.692

e-

=

+1.980

+
+
+

NHEa

4Br2Br4

c1-

+

"A1 25°C and I am.

and ligand stabilization on redox properties are also quite pronounced. The most common
oxidation state of silver is + I while for gold the +1 and +3 states are most common. In
aqueous solution, Ag", Agm and Au' are either unstable or form insoluble compounds.
However, in nonaqueous solvents, Au' can be stabilized by the appropriate ligand set.
Linear Au' compounds containing a combination of trialkyl or triaryl phosphine ligands
with an anionic ligand, such as thiolate or halide, are especially prevalent.
There is no doubt that the chemistry of gold and silver has expanded dramatically since
1980. However, electrochemical studies are still fairly limited compared with those of
other transition metals of biological importance. To our knowledge, no extensive reviews
have appeared on the electrochemistry of gold and silver complexes. Several reviews that
are more limited in scope have appeared in the literature and these are referenced in the
appropriate sections.
This chapter is organized by ligand type. This organization recognizes the importance
that ligand-metal interactions play in the redox chemistry of gold and silver compounds.
The general approach has been to offer an interpretation of trends in redox potentials as a
function of each ligand type. An extensive tabulation of physical and spectroscopic properties has not been included. The chapter is built around several core sections concerning
gold and silver interactions with carbon (phosphorus ylides and organometallics), biologically active molecules (drugs and phosphine gold thiolates) and complexes with promising
commercial applications (dithiolenes and dithiocarbamates). Other sections such as L2Au
and L,Ag, phosphine gold halides, and imides and anilides are provided to give coverage
to ligand types that are related to the core sections. Although comprehensive literature
citation of electrochemical studies was not the major goal, we hope that reasonably good
coverage of the core sections was achieved. finally, we have also included a brief survey
of a few other iigands and structural types where electrochemistry of gold and silver have
been reported.
The electrochemical investigations of gold and silver have employed a range of electrochemical techniques, working electrodes, solvents and reference electrodes. In compiling
the tables that appear in this chapter, a decision was made to report all potentials as
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TABLE 2. Conversion of reference electrodes and couples".
NHE

Ag/Ag+'

+0.241 V
+0.197 V

-0.559 V

-0.352 V

-

$0.549 V

-0.252 V

SCEb

AdAgCF

Fc/Fcfd

-

+0.045 V
-

-0.307 V

~

SCEb
AglAgCl'

-0.045 V

FC@C+~
NHE

+0.307 V
-0.241 V

$0.352 V
-0.197 V

-0.549 V

-

Ag/Ag+'

+0.559 V

$0.604 V

+0.252 V

$0.800 V

-0.604 V
-0.800

v

-

"Read across table and add voltage factor 10 conver7 from one reference electrode or couple to
another. All data taken from Reference 4.
bHg/Hg2Clz. KCI (sat'd).
=KCl (sat'd).
dReference 4. p. 701, FdFc+ couple in 0.2 M LiClO&leCN = +0.307 V vs SCE.
'Reference 4. p. 699.

_-

published using the reference system employed, and not to also report the potentials in
a common reference scale. An obvious disadvantage of this omission is that it makes
direct comparison between studies employing different reference systems somewhat cumbersome. However, we believe the decision is sound because a significant proportion of
the redox processes reported in this chapter involve irreversible electrochemical processes
measured in nonaqueous solvents. These redox processes are particularly sensitive to a
host of factors such as electrode, solvent, electrolyte and cell configuration, which in turn
affect capacitance, adsorption and cell resistance (iR drop).
Despite the caveat expressed above, it is still often useful to convert from one reference
system to another when discussing studies involving closely related compounds. Table 2
presents the conversion factors employed in discussions in the chapter. A survey of the
electrochemical literature reveals that differences in conversion factors exist. Thus, Table 2
is provided only for the purpose of approximating potentials in different reference systems.
The reader is referred to a number of excellent reference which discuss the complications
involved in rigorously converting reference systems5.
In compiling the redox couples for tables that appear in this chapter, we have routinely
rounded peak potentials to the nearest 10 mV. Redox potential values that appear to occur
outside the normal useful working range of a solvent at a particular electrode4 were not,
in general, included in the tables. For ligands that have common or easily recognized
abbreviations, these are also provided in the tables and may also be used in the text and
equations. For many of the-entries in the tables, notations have been made about reversible
(rev), quasi-reversible (qr) or irreversible (ir) processes.
11. DITHIOLENES AND DISELENOLENES

In 1,2-dithiolene complexes (or the selenium analogs), there is extensive delocalization
of the electrons through the rr system of the ligand as well as with metal dn orbitals of
the corresponding symmetry6. This extensive delocalization makes it possible for dithiolene complexes to exist with a range of electron populations. It also makes assignment
of the metal oxidation states ambiguous. The 1,2-dithiolenes are expected to have more
metal-ligand Ir-bonding than 1,l -dithiolenes (e.g. dithiocarbmates), which is evidenced
by the short M-S bond lengths and facile reversible redox reactions in the former. In contrast, 1,1 -dithiolene complexes, with strained four-membered chelate rings and deviation
from ideal coordination geometries, are expected to show less reversible redox behavior and have weaker M-S bonds than 1,2-dithiolenes6. Monomeric bis( 1,2-dithiolene)
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complexes may undergo one, two or three redox processes according to equation I , where
the two dithiolene ligands are represented simply by S 4 .
[M-S4I2-

f=;f

[M-S4]-

F====+ [M-S4Io __1 [M-S4]+

(1)

The expansion in dithiolene chemistry is due to a wide variety of applications of
this type of compound in fungicides, pesticides, fingerprint developers, specific analytical reagents and highly electrical conductors. There are a number of examples of
1 ,2-dithiolene and diselenolene gold complexes, but to our knowledge there are no examples of silver for which electrochemical data are available.
Electrochemical potentials obtained from cyclic voltamhetry studies of gold 1,2dithiolene and diselenolene complexes are listed in Table 37-21. These studies reveal
TABLE 3. Cyclic voltammetry data (V) of 1,2dithiolenes and 1,2-diselenolenes
Compound

Alternative
formula

Redox couples
1/O

[Au(mnt)21"

011-

+ I S 1 (rev)

1-12(rev)

-0%

8

MeCN
MeCN

9
10

CH2C12

I1

MeCN
MeCN

9
12

DMF

16

SCE

MeCN

17

SCE
SCE

MeCN

18

-1.57 (rev)

MeCN

19

FcfFc+

DMF

20

-1.61 (rev)

SCE

MeCN

19

-1.95 (rev)

Ag/AgCI04 DMF
SCE
MeCN
F&c+
DMF

19

20

FdFc+

20

+1.20 (rev)"

b
-1.10

[ A u ( C ~h
S I"
~
[Au(C3Se5)Z 1"

+0.72 (41)

-0.52

+0.34 (ir)

-0.70 (rev)

-1.32 (rev)

+0.10

+0.64 (ir)
+0.53 (qr)

+0.63

(i)
C

+0.37 (rev)
[Au(tdO21"
[A~(Bu-r-bdt)~]"
[Au(xdt)21n

f0.46 (qr)
+0.59 (u)
+0.22 (rev)

-1.59 (rev)

+0.25 (rev)

[Au(Meqbdt)Z]"

"Polarography at dme.
bNo wave found in the range 0 to -1.5 V.
=Not observed.

DMF

13

DMF

13

CH2c12
CHzClz

15

DMF

14

8

+O.M (rev)

FdFc+

DMF

20

+0.26 (rev)

FdFc+

DMF

20

+0.15 (ir)

FdFc+

DMF

20

fo.43 (ir)

Fc/Fc+

DMF

20

fo.29 (rev)

Fc/Fc+

DMF

20

+0.13 (rev)

FdFc+
DMF
Ag/AgCiO4 DMF

21

Fc/Fc+

20

[Au(tcdt)z]"
[Au(Naphdt)Z I"

7

SCE
SCE
SCE
SCE
SCE
SCE
SCE
SCE
SCE
SCE

+1.04 (ir)

[Au(diodh]"

-1.33 (ir) Ag/AgCl

-0.42 (rev)"
-O.6la

[Au(tds)Zl"

[A~Wthl"

CH2C12

2-/3-

DMF

-0.97 (rev)"

+1.28 (ir)

Ref.

Ag/AgClO4

+1.32 (rev)

[A~(CsH4Sshl"
[Mdpdt)zl"

Solvent

-0.96 (rev)"

[Au(tfdhl"

[Au(dddth]" +0.82 (qr) +0.41 (rev)
[Au(oxdtdt);?]"
f0.41 (rev)

Ref.
couple

- 1.67"

f0.51 (rev)

DMF

20
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a rich redox chemistry, consistent with the behavior of many other metal dithiolene
complexes. There are several prominent features of the data; the redox couples are
highly ligand dependent and many of the redox processes are reversible. Transition
metal complexes with the maleonitnledithiolate Ligand (mnt, I) have been intensely
studied since the mid-1960s when reports began to appear describing the ability of
mnt to form highly colored transition metal complexes in interesting oxidation states.
Cyclic voltammetry studies of square planar, [Au(mnt)2]- complexes have measured
the potentials for the O/l-, 1-/2- and 2-/3- couples. The first two redox couples are
reversible in CH2C1z7, DMF8 and MeCN9*" (see equations 2 and 3)?. A seemingly
wide range of redox potentials has been reported for the 1-/2- couple. However,
inspection of Table 3 reveals that the reference electrode/solvent systems employed are
largely responsible for this difference. For example, the 1-/2- couple at -0.96 V vs
Ag/AgC104 would be approximately -0.4 V vs SCE, which compares favorably with
other values reported for this couple. While the 2-/3- couple of the I C ~ ( m n t ) 2 ] ~ analog is electrochemically reversible, [Au(mnt)2]- shows an irreversible electrochemical
process in CHzClz at 200 mV s-l (equation 4)7. This was further investigated by infrared
spectroelectrochemistry which indicates that a chemically reversible process occurs at
longer timescales. These differences were attributable to kinetics of the reactions and the
electronic structure of the complexes.
[Au(mnt)zl+- e-

[Au(mnt>21-

+ e- +====+ [Au(mnt)2I2[Au(mnt)2I2- + e- --+ [Au(mnt)2I3-

[Au(mnt)z]-

(la) E = S , X = C N
(lb) E = s, x = c F 3
(1c) E = Se, X = CF3

(2a) E = S
(2b) E = Se

(3)

V

(2)

= -0.54 V

(3 1

E, = -1.33 V

(4)

El12 = f1.51

(4)

The O/l- couple in [Au(tfd)2]- (tfd = bis(trifluoromethyl)ethylenedithiolate, 1b)
occurs at a slightly lower potential (+1.32 V vs SCE in CHzC12) than the mnt
counterpart9.". This is in accord with observations that in other transition metal 1,2dithiolene complexes the ease of oxidation is dependent on X with X = Ph > CF3 > CN9.
Replacing sulfur with the less electronegative atom, selenium, results in a lower oxidation
potential for [Au(tds)z]- (tds = bis(trifluoromethyI)ethylenediselenolate, lc) relative to
[Au(tfd)z]- 12. More electronegative substituents make a complex easier to reduce, as
expected. Thus, the 1-/2- couple for [Au(mnt)2]- occurs approximately 500 mV more
positive than the same couple for [Au(tds)2]-.
Similar electronic effects are observed for the cyclic ligands, 2a and 2b. The sulfur
complex, [Au(C3S5)2]-, is oxidized quasi-reversibly at +0.72 V vs SCE (Figure l a ) while
the selenium complex, [Au(C3Sej)? J-, undergoes an irreversible oxidation at +0.34 V
(Figure lb)13. Assignment of the 0/1- couple as a ligand-based oxidation was made on
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I

I

- 0.8

I

I
- 0.4

I

I

0
E,V

YS

1

SCE

I

I

0.4

I

0.8

__

FTGURE 1. Cyclic voltammograms for 4.7 x
M compound in 0.1 M [BQNJCIO~IDMFat room
temperamre and Scan rate of 100 mV s-I: (a) 2a; (b) 2b. Reproduced by permission of the Royal
Society of Chemistry from Reference 13

the basis of ESR data, and is consistent with the electrochemical potentials observed. The
1-/2- couple for the selenium complex is reversible (Figure lb) and occurs at a lower
potential than for the sulfur counterpart. The reason for the differences in reversibility for
the sulfur and selenium derivatives is not apparent.
An interesting feature concerning the redox properties of the complex, [Au(dddt)2](dddt = 5,6-dihydro- 1,4-dithiine-2,3-dithhiolate,
3), is that the one-electron oxidized product, [Au(dddt)-Jo, can be i~olated'~.
An X-ray anaIysis of the neutral complex reveals
a square planar gold structure stacked in 'dimeric' units as a result of intermolecular
S - - - S contacts. Extended Huckel calculations predict that the odd electron resides primarily in a x* orbital of the ligand and suggests that oxidation of the monoanion is ligand
based. Oxidation of the neutral complex to the monocation was also reported to occur at
+0.82 V vs SCE14.
Incorporation of two of the sulfurs in an eight-membered ring has no apparent effect
on the O/l- couple, i.e. [Au(oxdt-dt)z]- (oxdt-dt = ortho-xylenedithiodithiolate,4) oxidizes at the same potential as [Au(dddt)z]-, +0.41 V vs SCE. The one-electron oxidized
product, [A~(oxdt-dt)2]~,
was also isolated and characterized by elemental analy~is'~.
Gold complexes of dithiolene ligands containing many sulfur atoms are expected to
be oxidized at lower potentials. This is demonstrated by [Au(Cg&S8)2]- (c8&& =
2-(4,5-ethylenedithio)- 1,3-dithiole-2-ylidene-1,3-dithiole-4,5-dithiolate,
S), which oxidizes
very readily to the neutral complex at +0.10 V vs SCEl6. The partially oxidized complex,
[Au(C8&S8)2]'++. could also be obtained, which is of interest for molecular conductivity.

159

9. The electrochemistry of gold and silver complexes

The 0/1- couple for [Au(dpdt)$ (dpdt = 6,7-dihydr0-6-methylene-SH- 1P-dithiepine2,3-dithiolate, 6) occurs at +1.28 V vs SCE, which suggests that the electronic properties
of dithiolene 6 are intermediate between mnt (la) and tfd (lb)I7. However, the 1-12- couple is reported at +0.63 V vs SCE, which is significantly more positive than the 1-/2couples for the other gold dithiolene complexes listed in Table 3. In addition, reduction of the monoanion, [Au(dpdt)z]-, is irreversible, in contrast to the other complexes,
suggesting that in this case the product dianion is unstable.
A dithiolene ligand incorporating an oxygen atom in the ring backbone has recently
been prepared and the corresponding nickel, copper and gold complexes were studied".
The gold complex, [ A ~ ( d j o d1) ~ (diod = 1,4-dithia-6-oxa-2,3-dithiolate,
7), which was
difficult to prepare, shows only a single irreversible oxidation at +0.64 V vs SCE. Reduction to the dianion was not observed up to -1.5 V vs SCE. Apparently, this dithiolene
ligand is less able to delocalize negative charge.
A large number of derivatives of [Au(bdt)z]- (bdt = benzene dithiolate, 8a) with different substituents on the aromatic part of the ligand have been prepared (8-11). The
monoanionic gold complexes are typically green and contain square planar AuU1. Oxidation to the neutral complexes occurs at low, positive potentials and is dependent on the
~ ~ .stability of the monoanion relelectronic properties of the aromatic s u b s t i t ~ e n t s ' ~ -The
ative to the dianion is greater for [Au(8)2]" than for [Au(mnt)21n. An SCF-HF calculation
using LANLlDZ core pseudopotentials was carried out on [Au(bdt)~]-*'. The calculation predicts that the HOMO is primarily a ligand-based TI orbital while the LUMO is a
mixed ligand/metal (cu 50% Au dxy) orbital (see Figures 2a and 3). The HOMO should
therefore be destabilized by electron-releasing substituents while the LUMO may be less
sensitive to substituent electronic effects. The electrochemical data are consistent with this
orbital description. Within series 9, the complex which is easiest to oxidize is [Au(9c)2]with two methoxy groups, while the complex which is hardest to oxidize is [Au(9f)2]-.
Note that the CV data for this series of complexes are referenced against the Fc/Fc+
couple and the sweep rate necessary to achieve chemical reversibility varied*'. Oxidation
of [Au(9e)2]- and [Au(9f)2]- was irreversible even at u = loo0 Vs-I, suggesting that
the neutral species was chemically unstable.
X

x
(8a) R = H

(8b) R=Me
(8c) R=t-Bu

(9a) X = Me
(9b) X = SCH3
(9c) X = OCH3
(9d) XX =-SCH2CH2S(9e) XX = -OCH2CH20-

xx

(90
= -SC(S)S(9g) XX = -SC(0)S-

(10a) X = Me
(lob) X = C1
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(b)

- L(n*)

- UT*)
- M(Pr)

LUMO+I

blu. 5.52 eV

o*(xy)hg 3.56 eV

n, (xz) bZg- 4.14 eV
~ ~ ( 2
b,,-4.98eV
)

HOMO
HOMO - 1

~ 0 ~ 0 - 2
n3(Z) bg-5.52eV

-

L(n)

- M(Pz)

I

2.46eV LUMO+ I

b,,

hg- 0 53 eV LUMO

a*(q)

nl (xz)bZs- 3.18 eV SOMO
n2 (2) bl,-7 10 eV

- n3 (2)
-L ( 4

b3,-8 53 eV

SOMO-I
SOMO-2

(la)

(1)

FIGURE 2. (a) Coordinate system of [Au(Sa)Z 1- used in the ab initio calculation; (b) electronic structure in the valence region of I = [ A U ( S ~ ) ~ (left)
) - and Ia = [ A U ( S ~J )(right).
~
Reprinted with permission
from Reference 20. Copyright (1995) American Chemical Society
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FIGURE 3. Valence molecular orbital basis function coefficients according to the ab initio calculations
on [Au(Sa)z]-. Reprinted with permission from Reference 20. Copyright (1995) American Chemical
Society
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The 1-/2- couple has been reported for only a few members of the [Au(bdt)z]series. However, the available data suggest that substituent electronic properties also
affect the reduction potential of the monoanion. The complex, [Au(tcdt);?]- (tcdt =
3,4,5,6-tetrachlorobenzene-]
,ZdithioIate, lob), with four electron-withdrawing chlorine
atoms, is easier to reduce (-1.67 V vs Ag/Ag+)*' than [Au(tdt)z]- (tdt = toluene-3,4dithiolate, 8b) with one electron-releasing methyl group (-1.95 V vs Ag/Ag+)'.
An SCF-HFcalculation on the neutral complex, [Au(bdt)z], reveals a similar ordering of
the frontier orbitals compared to [Au(bdt)2 1- but with significantly different energies (see
Figure 2b)20. Thus the calculation predicts that the odd electron in [Au(bdt)2] resides in
a ligand-based orbital, consistent with experimental results from other laboratories which
suggest that the 011- couple in An" dithiolenes is a ligand-based oxidation (vide supra).
Ill. DITHIOCARBAMATES

Electrochemical data for gold dithiocarbamate (dtc) complexes are listed in Table 4.
Van der Linden and coworkers studied a series of square planar Ad'' dithiocarbamates,
[Au(l2)#
and mixed 1,2-dithiolene and dithiocarbamate complexes, Au(mnt)(dtc) and
Au(tdt)(dtc)'o*22. Note that the potentials in these studies were all obtained using a rotating
TABLE 4. Electrochemical data (V)of 1.1-dithiolenes and mixed 1.1- and 1.2dithiolenes
Compound

Alternative Formula

Redox couples
110

- 0.29
-0.22'
-0.26a
-0.28'
-0.29
-0.19"

SCE
SCE
SCE
SCE
SCE
SCE
-0.46'
SCE
-0.41 (rev)'' SCE
-0.45 (IXV)"SCE
-0.46 (rev)' SCE
-0.87'
SCE

10
22
22
22
22
22
10
22
22
22

-0.80 (rev)' SCE
-0.11'
SCE

23
23

-0.82'

23
23

-0.19
-0.75'
-0.76b
"Rotating disk.
'Polargraphy .
cCyclic voltammetry.
d~~ = propytene carbonate.
cTol = toluene

Reference

oil-

-0.84'

-l.loc

Ref. Couple SolvenP

SCE
SCE
SCE
SCE
SCE
FdFc+

10

23
23
23
24
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Pt disk electrode'0*22.In contrast to the gold 1,2-dithiolene complexes, only one redox
couple has been reported for the complexes containing dithiocarbamates. The monocations reduce at less negative potentials than the neutral, mixed complexes. The 1/0 couple
for [Au(l2)2]+ is irreversible and is fairly insensitive to the substituents bonded to nitrogen. Similarly, in the mixed 1,l- and 1,2-dithiolene complexes, the 0/1- couple is more
sensitive to the nature of the 1,2-dithiolene ligand rather than to the substituents on the
1,l-dithiolene ligand.

(12a) R = H
(12b) R=Me
( 1 2 ~ )R=Et
(12d) R=Pr
(12e) R=Bu
(120 R=Ph
(12g) R=Bn
Reduction of a series of Aum dithiocarbamates, [Au(SzCNR2)3], R = Et (12c), Pr
(12d), Bu (12e) and Bn (12g), was investigated by polarography, chronoamperometry and
cyclic voltammetry at a mercury electrode23. All the complexes show one main reduction
wave in the polarogram in a fairly narrow potential range, -0.76 V to -0.82 V vs SCE.
Constant potential coulometry gave n values of 2.27-2.93 for the series. The nonintegral values for n are indicative of a chemical reaction coupled to the electron transfer
process. Cyclic voltammograms of the series were more complex than the polarograms.
For example, the cyclic voltammogram for [Au(l2c)3] is shown in Figure 4. The major
reduction peak at ca -1.4 V vs Ag/Ag+ (-0.8 vs SCE) is assigned as the 0/1- couple.

1
-2.0

i"\i
t

E (V) vs Ag/AgCIOd

FIGURE 4. Cyclic voltammogram for 4.0 x
M [Au(lk)3] in 0.2 M NaC104/propylene carbonate
at 25 "C and scan rate of 50 mVs-'. Reproduced by permission of The Australian Journal of Chemistry
from Reference 23
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There are also two smaller reduction waves at more positive potentials. Similar cyclic
voltammograms displaying three cathodic reduction peaks and two anodic oxidation peaks
were obtained for the other complexes in this series. The main reduction peak for each
gold complex is similar to the peak obtained from the polarographic study (see Table 4,
values labeled c). The nonintegral n values and the complex CVs were attributed to dissociation of the dithiocarbamate ligand upon reduction of Aunr(dtc)j to [A~'(dtc)3]~-,
followed by reaction of free dtc with the mercury electrode (see Scheme 1).
I A ~ ~ ' ( d t c ) 3+] ~2e[Au'(dtc)3J2(dtc)-

+

-

-

Hgo ---+

2 Hg'(dtc)

[Au'(dtc)3J2- (unstable)
Au'(dtc)

+ 2(dtc)-

Hg'(dtc)

+ e-

Hg"(dtc)z

+ Hgo

.

SCHEME 1

The final entry of Table 4 represents the only example we found of a silver dithiocarbamate complex for which electrochemical data have been reported24. Addition of AgBF4
to cobalt tris dithiocarbamate complexes has been reported by Bond and coworkers. In
the absence of silver, a fully reversible redox couple occurs which is assigned to the
[CO(S~CNR~)~]+/C~(S~CNR~)~
couple. When R = Pr (12d), this redox couple occurs
at +0.355 V (vs Fc/Fc+). Upon addition of AgBF4 to the toluene/CH2C12 solution of
Co(l2d)3 several new redox couples appear. The electrochemical data are consistent with
the existence and stability of the complex cation, [Ag{Co(l2d)3)2]+, in solution. Reduction of the complex cation occurs at cu - 1.1 V and this is assigned to a process involving
reduction of the silver ion. Oxidation occurs at +0.83 V which is assigned as involving
one of the cobalt dtc ligands. The solid state structure of [Ag(Co(l%d)3}2]BF4 reveals
a central Agf ion in a highly distorted tetrahedral geometry coordinated by four sulfurs
from the dtc ligands, bridging between Ag and Co. There is no direct Ag-Co bond. The
solution interactions of a number of cobalt, rhodium and indium tris dtc complexes with
Ag+ were also i n ~ e s t i g a t e d ~ ~ .

IV. L ~ A u
AND LnAg COMPLEXES
The series of gold(1) bis(dipheny1phosphine) compounds, [Au(l3a-d)2]+, shown in
Table 5, was studied extensively by McArdle and B ~ s s a r d ~Cyclic
~.
voltammetry at
a gold electrode shows diffusion controlled, reversible or quasi-reversible behavior
consistent with a two-electron process (Au'/'" redox couple) occurring at potentials
ca +0.6 V f 0.2 V YS SCE. Bulk electrolysis studies on [Au(13a)zJPF6 indicate that
2 electrons (1.81 and 1.83) are removed during oxidation at +0.7 V, while the peakto-peak splitting in the CV study was 37 mV, indicative of near-idealized two-electron
behavior (0.59Un). The other complexes showed similar CV peak-to-peak separations.
The bulk electrolysis experiment for [Au(13b)2]PF6 was complicated by decomposition
of the oxidized product and the generation of another redox active compound. This
prevented the authors from completing the electrolysis and resulted in an estimate for
the n value of >1.7 before the secondary process became significant- The oxidation
products of [Au(13c)z]PF6 and [Au(13d)z]PF6 were too unstable for the authors to attempt
bulk electrolysis experiments. McArdle and Bossard were also able to gain significant
insight into the electrochemical process by performing UV-vis-spectroelectrochemistry
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TABLE 5.
n = 1,2)

Cyclic voltammetry data (V) of LzAu and L,Ag complexes (L = phosphine or m i n e ,

Compound

Alternative Formula

Oxidations

Reductions Ref. couple Solvent Reference

[ A 4 1 3 a h I+

[Au(dppb)z]+

+0.46 (rev)

SCE

MeCN

[Au(13b)zlf
[ A u ( l k ) z I'

[Au(dppen)zl+
jAu(dppeh1'

+0.57 (qr)
$0.46 (qr)

SCE
SCE

MeCN
MeCN

/Au(lWzJi

IAu(dppp)z I'

+0.75 (qr)

SCE

MeCN

Au[P(C6H5)31zt
Au[P(OCz H h I z '

+0.78 (ir)
+1.10

SCE
SCE

MeCN
MeCN

Ag(Wf

+1.17 (qr)

Ag/AgCl

Acetone

25
25
25
25
26
26

27

Au(15a)z3+

-0.45 (ir)

Ag/AgCIO4 MeCN

28

Au(15b)z3+

-0.17 (ir) Ag/AgC104 MeCN

28

Ag( 15a)z3+

-0.03 (ir) Ag/AgC104

MeCN

28

Ag(l5b)z 3+

f0.26 (ir)

MeCN

28

Ag/AgCI04

on [A~(13a)z]PF6~'.During oxidation at +1.26 V they found clean conversion of one
species to another as evidenced by a series of isosbestic points. They proposed that during
oxidation, tetrahedral gold(1) is converted to square-planar gold(II1). The differences in the
electrochemical behavior of the series were proposed to be a consequence of the lability of
the gold-phosphorus bond and the overall rigidity of the four-coordinate gold compounds.

(15a) E = P

(15b) E = A s

Anderson and coworkers investigated the effect of added phosphine to solutions of
Au(PR3)CIz6, which results in additional phosphine ligands attaching to a central gold(1)
atom as shown in equation 5.
Au(PR3)Cl+ ( n - l)PR3 F==+ Au(PR3),+

PR3 = PPh3 or P(OC;!Hs)3,

+ CI-

n = 2-4

(5)
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Conductivity data show that adding PPh3 to the nonelectrolyte solution of Au(PPh3)CI in
MeCN produces a weakly conducting solution at 1-2 equivalents of PPh3, and a strongly
conducting solution at > 4 equivalents of PPh3, indicative of the presence of a 1 : 1
electrolyte. By keeping the amount of added phosphine low, Anderson and coworkers
ensured that &hemultiple equilibria implied in equation 5 involved predominately n = 1
and 2, thereby allowing them the opportunity to investigate the electrochemical oxidation of [Au(PPh3)2]+ and [Au(P(OC2Ng)3)2]+ (see Table 5). Interestingly, the cationic
complex, [Au(PPh3)2]+, is easier to oxidize than Au(PPh3)CI (+1.54 V vs SCE)26 suggesting that the CI- ligand stabilizes and 'protects' the gold from oxidation. Substituting
the triphenylphosphine ligand by the electron-withdrawing triethylphosphite shifts the
Au'/"' couple to higher potentials, as expected.
The silver diiminodiphosphine complex, Ag(14)+, was investigated electrochemically
by using a Pt working electrode in 0.1 M tetraethylammonium perchlorate/acetone
solution2'. The quasi-reversible redox couple, Ag(14)C/Ag(14)2+, occurs at + 1.17 V
(vs Ag/AgCl). Comparison of the oxidation potentials of the four-coordinate gold(1) bisphosphine complexes, [Au(l3a-d)2]+, shown in Table 5, indicates that the silver complex
is on average 0.5 V harder to oxidize, which is in line with expectations from comparisons
of the Ad/" and Agr/" redox couples discussed in the introduction. Rauchfuss and
coworkers also reported that the fully reversible Cu'/" redox couple found for the copper
analog, Cu(14)+, occurs at +0.77 V (vs Ag/AgC02'.
Reduction of the gold and silver complexes of 15a,b was investigated by cyclic
voltammetry at a Pt electrode28. These data afford an interesting comparison of the electrochemical behavior of Au vs Ag and P vs As. The Au"' complexes are harder to reduce
than the corresponding Ag'" complexes, which reflects the relative chemical stability of
Au" and Ag"'. The Agnr complex, [Ag(lSb)2](C104)3, decomposes readily in the presence of water, chloride and many organic solvents23. A qualitative comparison of the
reduction potential of [Au(l5a)2l3+ (-0.45 V vs Ag/Ag+ or cu +0.15 V vs SCE) with
the reversible redox couple for [Au(13a)2]+ (+0.46 V vs SCE) is also in line with the
difference in electronic properties of methyl vs phenyl groups on P.

V. PHOSPHINE GOLD HALIDES
The electrochemical properties of phosphine gold halide compounds have been the subject
of a number of investigations. Anderson and coworkers26 reported that Au(PPh3)CI and
Au(PEt3)CI undergo oxidations at 1.54 V and 1.51 V, respectively (vs SCE), in MeCN
solutions at 100 mVs-* (see Table 6). The oxidation process for Au(PEt3)CI involves a
broad irreversible oxidation wave, is diffusion controlled (i.e. iP/v1i2 is constant) and
the value of Epashifts positively with an increase in scan rate. On the basis of cyclic
voltammetry, bulk electrolysis and UV-vis spectroelectrochemistry studies, the authors
conclude that an overall two-electron oxidation of Au' --+ Au"' occurs, followed by a
fast chemical reaction. The n value for bulk electrolysis of Au(PEt3)CI was 2.0 f 0.5.
Cyclic voltammetry studies for Au(PEt3)CI show no reduction process out to -2.0 V,
except when the oxidation wave at 1.S 1 V is first scanned, whereby a reduction wave at
+0.20 V is observed. The observation is made that the presence of a reduction wave at ca
0.2 V implies formation of a gold(II1) ionic species, similar to the reduction wave which
appears for K [ A u C ~ ] * In
~ . addition, reduction of [AuCbJ- in the presence of phosphine,
PR3, regenerates Au(PR3)Cl. Spectroelectrochemical data show that upon oxidation of
Au(PEt3)CI at + I .45 V (vs Pt pseudoreference) a band at 3 10 nm appears. This band is
assigned to AuCL-. The electrochemistry of Au(PPh3)CI was found to be very similar.

+

+

+
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TABLE 6.

Electrochemical data (V) of phosphine gold halide complexes

Compound
Au(PPh3)Cl
Au(PPh3)CI
Au(PPh3)CI
Au(PPh3)CI
Au(PPh3)Br
Au(PPh3)Br
Au(PEt3)Br
Au(PPh3)I
Au(PEt3)CI
Au[P(OCzH5)3ICI
Au[P(OC& 13 lc1
Au(l6)CI
Au( 16)B r
Au(PPh3)Cb
Au(PPh3)Bu
Au(16)Cb
Au(lQBr3
Au(l7)CI
Au(1RCI

ox.

Ref. couple

Solvent

Reference

Ag/AgCI
SCE
FcJFc+
SCE
Ag/AgCI
FcJFc+

MeCN
MeCN
CHzClz
MeCN
MeCN
CHzCl2

29
26
30
31
29
30

+1.12

SCE

MeCN
MeCN
MeCN
MeCN
MeCN
CH2CIz
CH2C12
CHzCl2
CH2C12
CHzClz
CH2C12
MeCN
MeCN

29
29

+1.75

AdAgCI
AdAgCI
SCE
SCE
SCE
Fc/Fc+
FdFc+
FclFc+
Fc/Fc+
Fc/Fc+
Fc/Fc+
SCE

+ 1.58

+ 1.54

Red.
- 1.76
+0.03a

+1.13

+1.52
+1.31

-1.71

+1.14

+1.38
+1.05
+1.51

-1.76

- 1.54
+0.2v

+1.86
+1.76
+1.07
+1.03
-0.49

-0.31
-0.49
-0.37

26
26
26

30
30

30
30
30

30
31
31

uReduction wave appearing after oxidation.

Two other studies have appeared which also assign the oxidation of Au(PPh3)Cl as
involving a two-electron Au' -+ Aum irreversible proce~s~'.~'.
In contrast, Rakhimov
and coworkers have recently suggested that the oxidation of Au(PPh3)Cl is a one-electron
process involving p h ~ s p h i n e Their
~ ~ . analysis is based, in part, on similar oxidation currents observed in cyclic voltammetry experiments of Au(PPh3)CI solutions containing
equal concentrations of ferrocene, a well-known one-electron redox couple31
Substituting alkyl phosphines for aromatic phosphines or phosphites has only a minor
effect on the oxidation potentials in two separate ~ t u d i e s ~Substitution
~,~~.
of less electronegative halides for chloride might be expected to make the oxidation of gold(1)-halide
moieties easier. This was indeed observed in cyclic voltammetry studies in 0.05 M
[EbN]BF4/MeCN solution at a Pt working electrode where Au(PPh3)Br and Au(PPh3)I
are 27 mV and 53 mV, respectively, easier to oxidize than A u ( P P ~ ~ ) C
However,
~~~.
Nelson and coworkers found little change when Br- is substituted for C1- in cyclic
voltammetry experiments run in 0.1 M [ B Q N ] C ~ O ~ / C H ~solution
CI~
at a Pt working
electrode: oxidation of Au(PPh3)Br occurs at +1.14 V and for Au(PPh3)CI at f1.13 V
vs Fc/Fc+ (see Table 6)30.The oxidation potentials of gold(1) I-phenyldibenzophosphole
(16) halide compounds are also insensitive to halide substitution. Oxidation of Au( 16)Cl
occurs at +1.07 V vs Fc/Fc+ and for Au(l6)Br at +1.03 V30. In fact, all four compounds
investigated by Nelson and coworkers are reported to oxidize within a narrow range
1.09 V f 0.06 V ( v s Fc/Fc+)~O.Substitution of more electronegative halides for bromide
might be expected to result in making reduction of gold(II1) easier. Nelson and coworkers
~
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observe this for AuLX3 compounds (L = PPh3, 16; X = C1, Br) where substitution of
Br- for CI- decreases the average Au(UI) reduction potential by 150 mV3'.

Ligand 17 is believed to act as a monodentate Iigand for Au', coordinated through the
phosphine only, on the basis of I3C NMR data which show that the aromatic carbon
atoms bonded to nitrogen remain practically unchanged, in contrast to the carbon atoms
bonded to phosphorus which are shielded after complexation. The oxidation of Au(l7)CI
and Au(l7)zCI complexes was studied by Castan and coworkers3'. The major anodic
process of Au(l7)Cl is an irreversible wave occumng at +1.75 V (see Table 6) which is
assigned as Au' to Au"'. A shoulder at +0.95 V occurs which is assigned to oxidation
of the free ligand (+0.87 V vs SCE). In the cyclic voltammogram of Au(l7)2CI, there is
also a shoulder at ca 0.95 V and a major oxidation wave at +1.12 V, which is assigned
as a Au' + Au" oxidation. The authors suggest that increasing the coordination number
around gold from two in Au(l7)CI to three in Au(l7)zCI is responsible for decreasing the
oxidation potential. This observation is further supported by comparison with the redox
couple for the four-coordinate Au' complex, [Au(l3a)*]+, found in Table 5. This simple
relationship is illustrated in Figure 5.
2.0

0.0

I
2

I

I

3

I

4

Coordination Number

FIGURE 5. Oxidation potentials vs coordination number: W Au(l7)CI, +1.75 V; 0 A ~ ( 1 7 ) ~ C l ,
+ I . 12 V; A [Au(13a)z If.+0.46 V. All potentials vs SCE
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VI. PHOSPHJNE GOLD THIOLATES AND MIXED DONOR LIGANDS

The electrochemistry of a series of neutral phosphine gold(1) thiolate complexes has
~ , ~ series
~.
includes cyclic dinuclear goId(1) complexes formed
been i n v e ~ t i g a t e d ~The
from 1,2-propanedithiolate (pdt, 18) and bis-chelating phosphines, Au2(13c,g)(18), open
dinuclear gold(1) complexes formed from para-thiocresolate (p-tc, 19) and bis-chelating
phosphines, Auz(13c-g)(19)2, and a mononuclear complex, Au(PPh3)( 19). Oxidative
cyclic voltammetry experiments were performed at Pt and glassy carbon electrodes
in 0.1 M [Bu4N]PF6/MeCN and CH2C12 solutions. Adsorption effects occurred in all
electroddsolvent combinations investigated and were minimized by wiping the electrode
between each CV experiment. Scan rates between 50 and 500 rnVs-' were employed
and several replications at each scan rate were obtained. Table 7 shows the results
of the oxidative cyclic voltammetry experiments at a Pt working electrode in 0.1 M
[B u N ] P F ~ / C H ~ Csolu
I ~ t ion.

The position and wave shape of the oxidation processes were somewhat dependent on
the electrodekolvent combination. The effect of changing the solvent from CH2C12 to
TABLE 7. Cyclic voltammetry data(V) of phosphine gold thiolate and mixed donor ligand complexes'
Compound

Alternative formula

Oxidations

Au2(1k)(18)

Au~(dppe)(pdt)

+0.77'

Auz(13g)(18)
Au(PPh3)(19)

Auz(dpppn)(pdt)
Au(PPh3)(p-tc)
Auz(dppm)(p-tc)z
Auz(dppe)(p-tc)~
Au2(dppp)(p-tc)z
Auz(dppb)(p-tc)2
Au2(dpppn)(ptc)z

+0.63 (ir)
+0.82 (ir)
+0.58' (ir)
$0.72 (ir)
+0.77 (ir)
+0.83 (ir)
+0.78 (ir)
1.42 (ir)
+ I .46 (ir)

Auz(l&)(19)2
AU2(1k)(19)2
Auz(13d)(19)2
AU2(13f)(19)2
Au2(13g)(19)2
[Auz(1W(20)lf
[Au~(JW(~O)I'
IM21)zl'
22a
22b
22c
23a
23b

+

(ir) f1.20 (ir)

+1.23 (ir)
+IS2 (ir)
+1.52c (ir)
+ I S 4 (ir)
+1.54 (ir)
+1.59 (ir)
+ I .56 (ir)

Reductions

Solvent

Reference

CHzClz

32

CH2CI2
CH2C12
MeCN
CH2C12
CH2C12
CHzCl2
CH2C12
CH2CI2
CH2C12

32
32
33
32
32
32
32
34
34

-0.86 (rev) MeCN
+0.26 (rev) +0.59 (rev) - 1.22 (ir)
MeCN
t0.32 (rev) +0.68 (rev) - 1.18 (ir)
MeCN
+0.65 (rev)
-1.0 (ir)
MeCN
+ 1.2 (ir)
t0.08 (rev) MeCN
+ I .2 (ir)
-0.10 (rev) MeCN

35
36
36

36
37
37

uAII studies employed a €3working electrode except as noted. Reference was SCE in all studies, except Reference 35
which was Fc/Fc+.
bAdsorption wave appears at t 0 . 4 7 V.
'Glassy carbon working electrode.

169

9. The electrochemistry of gold and silver complexes
MeCN in cyclic voltammetry experiments of Au2(13c)(18) at glassy carbon is illustrated
in Figure 6. The broadness of the irreversible oxidation wave shown in Figure 6b was
noted in the study3'. The difference between the potential maximum and half currents
( E p , - Epa/2) was found to be 150 mV. A similar observation about broadness in the
oxidation wave of phosphine gold halide complexes was made by Anderson and coworkers
during investigation of the oxidation of Au(PEt3)ClZ6. The first oxidation process of
all complexes shown in Table 7 occurs at +0.7 V f 0.1 V (vs SCE), with the possible
exception of Au2(13c)(18) for which the presence of an adsorption wave at t0.47 makes
the exact potential of the first oxidation process somewhat difficult to determine. The first
oxidation process is followed by a second one which occurs between +1.2 V and +1.6 V
(see Table 7). With the exception noted for Au2(13c)(18), substituting aromatic thiolate,
19, for alkyl thiolate, 18, shifts both the first and second oxidation processes to lower
potentials. Figure 7 shows the 0.0 V to +2.0 V cyclic voltammograms for Au2(13c)(18)
and Au2(13g)(18) in CH2C12 or MeCN solutions. Lengthening the bis-chelating phosphine
from 13c to 13g has only a small effect on the overall cyclic voltammogram waveshape
(compare Figure 7a and 7c). It has been noted that for a particular solventlelectrode
combination the first oxidation wave broadens as the length of the bis-chelating phosphine
becomes very short (i.e. 13e, not shown) and may indicate weak coupling of the two
gold(1) redox centers33.
Comparison of the oxidation processes of Au(PPh3)X (see Figure 8, X = halide) shows
an inverse linear relationship between the oxidation potentials and the electronegativity
of the X ligand. Since the electronegativity of sulfur is similar to iodine, oxidation of
phosphine gold thiolate complexes may be expected to occur near f l . O V. However, as
shown in Table 7, the first oxidation occurs at ca 200-400 mV lower potential. In addition, constant potential electrolysis studies at +1.0 V result in formation of the disulfide,
P - C H ~ C ~ H & S % & C H ~ -and
~ n values of 1 and 0.5 for the dinuclear and mononuclear
gold(1) complexes, respectively. The lowest transition state energy of phosphine goId(1)
thiolate complexes has been assigned as a sulfur-to-metal charge transfes'. This assignment and the formation of disulfide are consistent with sulfur-based oxidation, in contrast
to Au(PPh3)X where gold-based oxidation was suggested by several author^^^,^',^'. This
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FIGURE 6. Cyclic voltammograms at a glassy carbon electrode at room temperature and scan
rate of 50 rnVs-': (a) 4.7 x lo-' M Au2(13c)(lS) in 0.1 M [Bu4N]PF6/MeCN; (b) 4.8 x lop4 M
Au2(lk)(l8) in 0. I M [ B Q N ] P F ~ / C H ~ CReproduced
~~.
by permission of Freund Publishing House
from Reference 32
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FIGURE 7. Cyclic voltammograms at a glassy carbon electrode at room temperature: (a) 4.8 x lo4 M
Au2(13c)(18) in 0.1 M [BU&]PF~/CH~CI~
at scan rate 200 m v s - ' . (b) 4.7 x
M Au2(1k)(18)
in 0.1 M [Bu4N]PF&leCN at scan rate 50 mVs-'. (c) 4.8 x loa M Au2(13g)(lS) in 0.1 M
[BuN]PF~/CH~CI~
at scan rate 100 mVs-l. Reproduced by permission of Freund Publishing House
from Reference 32

difference may be significant for the biological activity of phosphine gold thiolate complexes such as Auranofin, since the redox chemistry of gold(1) centers interacting with
tho1 groups of proteins and enzymes may be critical to the mechanism of action of a drug.
The electrochemistry of gold(1) complexes with pyridine-2-thiolate, 20, was investigated by Laguna and coworkers34. The gold(1) cationic complexes [ A u ~13e)(20)1+
(
and [Au2(13c)(20)]+ undergo irreversible oxidations at +1.42 V and +1.46 V, respectively, during cyclic voltammetry experiments at a Pt disk working electrode recorded at
200 mVs-' in 0.1 M [ B U ~ N ] P F ~ / C Hsolution.
~ C ~ ~ No reduction waves were observed
out to -1.8 V. The reference electrode was SCE, which was standardized against either
the Fe(r&Hs)2]+-[Fe(q-C-jHs)2] or the [Fe(r7-CsMes)2lf-[Fe(rl-CsMes)2Icouple as
an internal standard (Eo = 0.47 and -0.09 V, respectively).
The electrochemistry of a square-planar gold(II1) complex with 2-(diphenylphosphino)
benzenethiolate (21) was reported by Dilworth and coworkers35. Cyclic voltammetry
experiments on [Au(21)2]BPh indicate a reversible redox couple at -0.862 V (vs the
Fc/Fc+ reference couple) in 0.2 M [ B u ~ N I B F ~ N ~solution.
CN
Peat-to-peak separation
of the redox waves was 84.2 mV and convolution methods were used to establish that
the redox couple was reversible and involved the same number of electrons as the
femocenelferrocenium couple under identical conditions. The reductive scan was assigned
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FIGURE 8. Electronegativity of halides vs oxidation potentials of phosphine gold0 halides: (a)
Au(PPh3)CI, +1.54 VZ6; (b) Au(PPh3)Br. + I 2 7 VZ9; (c) Au(PPh3)I. +1.01 VZ9. The oxidation
potentials of Au(PPh3)Br and Au(PPh3)I were converted to the SCE scale using Table 2

as Au"' -+Au". The reversibility of the redox couple under slow scan rate conditions
(50 mVs-I) indicates that the gold(I1) complex is stable over the time scale of the
electrochemical experiment. In contrast, the neutral Pt(I1) and Pd(1I) analogs, Pt(21)2
and Pd(21)2, are electrochemically inactive over the accessible range of DMF (-2.4 V
to +1.2 V relative to ferrocene).
The synthesis, characterization and electrochemical investigation of an interesting series
of gold(I1) complexes with o-aminobenzenethiolate ligands has been reported by Gosh,
Manoharan and coworker^'^. The ligands are noteworthy, because they have both hard and
soft donor atoms which may contribute to stabilizing gold(I1) complexes. The dinuclear
gold(I1) complex, 22a, is prepared by the reaction of NaAuC4 with o-aminobenzenethiol.
The isomer, 22b, forms after refluxing 22a for 2 hours in dry, degassed methanol, while
the mononuclear complex, 22c, is formed upon dissolution, refluxing and workup of 22a
in DMF. ESR measurements in DMF solution on 22a and 22b show a seven-line pattern
(1 : 2 : 3 : 4 : 3 : 2 : 1) assigned as two interacting gold(I1) nuclei (Au, I = $, 100%). The
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mononuclear complex, 22c, shows a four-line pattern. Close agreement between the ESR
experimental results and simulation was found. Cyclic voltammetry experiments at a Pt
working electrode in 0.1 M [Et4N]C104/MeCN solution at 50 mVs-' show two sets of
reversible redox couples for 22a and 22b and one for 22c (see Table 7). The small shifts
in the pairs of redox couples for 22a and 22b support the idea that these complexes are
isomers with gold(I1) atoms in slightly different electronic environments. The complexes
22a-c all display a broad irreversible reduction wave at ca -1.0 V, presumably due
to reduction of Au" to Au'. The o-aminobenzenethiol ligand does not show any redox
behavior in this region.

QNH*

I

H2

Ghosh, Manoharan and coworkers have also reported on a pair of isomers formulated
as shown below, 23a and 23b37. Four-line patterns were observed in the ESR of each of
these complexes which appear to originate from one interacting gold nucleus. The authors
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suggest that the complexes have Au(I1)-stabilized radical structures containing oxidized
ligands where the unpaired electron is highly delocalized onto the ligand. Cyclic voltammetry experiments demonstrate that the redox behavior of these complexes is somewhat
complicated, in contrast to the relatively well-behaved features found in 22a and 22b.
On oxidative scans, both complexes show irreversible oxidation processes occurring at
about +1.2 V. On reductive scans, a reversible couple occurs near t O . 1 V, but there is
also a broad reduction wave at ca +0.35 V that appears coupled to two successive oxidative processes occumng near +0.4 V and +0.6 V. The origin of these redox features is
not discussed.

l+

l+

VII. PHOSPHORUS YLIDES
Dinuclear gold(1) and gold(I1) phosphorus ylide complexes have been the subject of several separate electrochemical investigations by Fackler and coworkers39 and Laguna and
c ~ w o r k e r s ~The
~ , ~neutral,
~.
cyclic bis-ylide, gold(1) complex, 24, undergoes two quasireversible, stepwise oxidations at +O.f 1 and +0.24 V (vs Ag/AgCi) (see Table 8)39. The
stepwise oxidations presumably involve one electron each, to form a gold(I1)-gold(II)

174

Ahmed A. Mohamed, Alice E. Bruce and Mitchell R. M. Bruce
complex. Precipitation of a yellow compound complicated efforts of further electrochemical analysis. The cyclic gold(I1)-gold(I1) halogen adducts, 25a-c, all show one
irreversible reduction wave and the potentials are dependent on the nature of the halogen
l i g a n d ~ The
~ ~ . reductions are followed by a chemical reaction that generates 24, which
can be clearly detected electrochemically. Bulk electrolysis of the Au(I1) halogen adducts
yields an n value of 2 electrons per molecule. For 25c two quasi-reversible oxidation
waves are seen, whereas for 25a and 25b only ill-defined, irreversible oxidation processes
are observed. The electrochemistry of 25d and 25e is complicated by an equilibrium
that involves 24 which results in deteriorating electrochemical signals39. Therefore, the
potentials listed in Table 8 for 25d and 25e were obtained under conditions of excess
alkyl halide.

X

/

PPh2

(25a)
(25b)
(25c)
(25d)
(25e)

Y
X=Y=C1
X=Y=Br
X=Y=I
X = Me, Y = Br
X = Me, Y = I

Cyclic voltammetry experiments on cyclic, dinuclear goldo) ylide dithiocarbamate complexes, 26a-c, show irreversible oxidation processes between +0.30 V and +0.4 V (see
Table 8)40. Electrochemical analysis was complicated by formation of a coating on the F’t
electrode surface. These complexes oxidize at potentials which are intermediate between
TABLE 8. Cyclic voltammetry data (V) of phosphorus ylide complexes
Compound

0x1

24
25a
25b

$0.24

25c

+1.12

25d
25e
26a
26b
26c
27
28a
28b

0x2

Red 1

Red2

+0.11

+IS

+ 1.22
+0.88
+0.38
+0.42

-0.92 (ir)
-0.69 (ir)
-0.58 (ir)
-0.75
-0.68

+0.30 (ir)
+0.37 (ir)
+0.42 (ir)
t0.53 (ir)
a
(I

-0.44 (ir)
-0.43 (ir)

‘Oxidation wave observed at +0.55 (ir) after reduction

-1.18

-1.14

Refxouple

Solvent

Reference

THF

39
39
39

Ag/AgCI
Ag/AgCI
Ag/AgCI
Ag/AgCI
Ag/AgCl
Ag/AgCI

THF
THF
THF
THF

SCE
SCE
SCE
SCE
SCE
SCE

CHzCl2
CHzClz
CHzClz
CHzCl2
CHzClz
CHzCl2

THF

39
39
39
40
40
40
34
34
34
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R

rAu-StN/

\
Ph2PL*Us
R
(26a) R = M e
(26b) R = E t
(26c) R = B n
those of [Au~{,u- S*CN(CH2Ph)2)2] (irreversible wave at f1.15 V)40 and 24. Increasing the electron-donating ability of the substituent groups on the dithiocarbamate ligands
from Bz to Me leads to a decrease in the oxidation potential.
Dinuclear gold(1) and gold(I1) complexes of pyridine-2-thiolate, 27, 28a and 28b, were
studied by cyclic voltammetry at a Pt working electrode in CH2C1234s The dinuclear
gold(1) complex, 27, has an irreversible, extended oxidation process at +0.53 V vs SCE.
No reduction wave was observed out to -1.8 V. The cyclic voltammograms for the
dinuclear gold(I1) complexes show irreversible reduction waves at -0.44 V (28a) and
-0.43 V (28b). After reduction, the return oxidation scan shows an irreversible oxidation
process at +0.55 V, indicative of the presence of 27.
X

I

(28a) X=C1
(28b) X = B r

VIII. ORGANOMETALLICS
The electrochemistry of a fairly large number of organometallic gold compounds has been
studied (Table 9). With few exceptions, these complexes also contain a triphenylphosphine
(or a derivative) ligand. Many of the compounds exhibit ‘typical’ linear, two-coordinate
gold, with the organometallic ligand coordinated to gold through a Au-C single bond.
Gold-gold bonding is also possible, and there are several examples of three-coordinate
gold organometallic compounds that have been investigated.
The prototypical gold(1) organometallic compounds are Au(PPh3)R (R = Me, Ph). They
are oxidized at +1.6 V (vs Ag/AgCI) and reduced at ca - 1.6 V (see Table 9)29. Comparing these potentials with those for Au(PPh3)X (X = CI, Br and I, Table 6) suggests that
the alkyl and aryl groups in Au(PPh3)Me and Au(PPh3)Ph, respectively, are electronically
similar to the chloride anion. The effects of different substituent groups on the oxidation
potentials of a series of Au(PPh3)R compounds can be explained on the basis of simple electronegativity arguments. Placing an electron-donating rnethoxy group in the para
position of the aryl group makes oxidation of Au(PPh3)(4-MeOC&) ca 300 rnV easier
than for Au(PPh3)R (R = Me, Ph), while a para fluoride makes Au(PPh3)(4-FC6Hq) ca
400 mV harder to oxidize. Cyanide has a similar effect (R = CN, CH2CN etc.), as do
the other electron-withdrawing groups, CH(COR)2 (R = Me, Ph or t-Bu). Note that the
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TABLE 9. Cyclic voltammetry data ( V ) of organometallic complexes
Oxidatlons

Compound
Au(PPh3)Me
Au(PPh3)Ph
Au(pPh3)(4-h'leOC&)
Au(PP~~)(~-FC~&)

f1.59

Reductions

Conditions

Reference

+1.61, +1.97
+1.28, +1.71
+2.00

- 1.63
- 173
b
b

+2.25
+2.24

-0.78~

C

29

Au(PPh3)CHzCN

-0.98b

C

29

Au(PPh3)CH(COOEt)CN
Au(PPh3)CMe(CN)z
Au(PPh3)CH(COMe)z
Au(PPh3)CH(COMe)(COPh)
Au(PPh3)CH(COPh)z
Au(PP~~)CH(COBU-~)~

+2.17
+2.30
+2.00
+2.05
1.96
1.86

-0.796
-1.00,-1.91
-1.64

C

a

29
29
29
29
29
29

a

41

a

e

41
42
42
42

e

42

e
e
e

42
42
42
43
43

Au(PPh3)CN

+
+

A u ( P P ~ F c ~ ) ( ~ - F G ~ & ) ~ +0.61, +0.80, +2.w
Au(PFc~)(~-FC&)~
+0.57, +0.72, $0.86, +2.13
29a
+0.76 (ir), + 1.01 (qr)
29b
+0.74 (ir). 1.03 (qr), +2.05
29c
+0.78 (ir). +1.05 (qr), +1.66,
+1.73, +1.88
29d
+0.74 (ir), +1.05 (qr), +1.27,
1.39, 1.54, 1.70
29e
+0.66 (ir). +1.08 (qr), +1.97
2%
+0-95 (ir), + I . I I (qr)
+0.93 (ir), +1.11 (qr)
29g
29h
+0.98 (rev)
2%
1.03 (rev)
3Oa
t0.24
30b
t0.81
31a
+0.68, +1.62
31b
+0.88, +1.81
32
+0.72, +2.21
33
+0.48, +1.36, +1.97
34
+1.52, +1.94
35
+0.79, +1.08, +1.41, t-2.04,
+0.84
36

-1.60
- 1.56
-1.60,-1.78
b

b

+

a
a
a

c
a
a
a

e

+

+

a

e

+

f
f

+

b

29
29
29
41

- 1.669

a

- 1.62

a

-1.77
-2.21
- 1.84
b
- 1.36

a
a

44
44
44
44
44

a
h
h

29
29
29

-0.62.-0.84

i

45

a

working electrode. 0.05 M [EtqN]BF.&leCN, Ag/AgCI reference couple.
bNo reduction observed at a Pt working electrode.
'=Droppingmercury electrode.
d~~ =ferrocenyl.

eGlassy carbon working electrode, Ag/AgCI reference couple in CHzC12. potentials reported
~ S C reference
E
in C H ~ C I ~ .
gReduction of the nitro group.
hAg/AgCI reference couple in hleCNICHzCI2 (I: 10).
'SCE reference in MeCN.

v5

SCE.

177

9. The electrochemistry of gold and silver complexes
electron-releasing t-butyl groups in Au(PPhs)CH(COBu-t)2 have only a modest effect on
the oxidation potential.
Replacing triphenylphosphine with ferrocenyl-derivatized phosphines adds additional
redox centers with very rich organometallic chemistry of their own46. The cyclic voltammogram of A u ( P P ~ F c ; ! ) ( ~ - F C ~shows
H ~ ) an oxidation process at ca +2 V, simdar to that
of A u ( P P ~ ~ ) ( ~ - F Cand
~ Htwo
~ ) , additional redox processes at +0.61 V and +0.80 v that
appear to be associated with coupled, iron-based redox processes.
A number of dinuclear gold(1) complexes containing the 1, 1'-bis(dipheny1phosphino)ferrocene (dppf) ligand, 29a-i, have been analyzed e l e c t r ~ c h e m i c a l l y ~
On
~ ~the
~ ~basis
.
of
the above discussion, two oxidation processes are expected, one that is ferrocenyl-based
and the other associated with the organogold fragment. Indeed, this is what is reported
for 29a. However, the situation is obviously more complicated for the other dinuclear
gold(1) complexes (29b-i), where up to six anodic processes are reported in the range
of 0-2 V (see Table 9). In the dppf chemistry of other transition metals, the dppf ligand
is often found chelated to a single
This suggests that in solution the two Au'R
redox centers might easily encounter each other to produce redox coupling, resulting in
splitting of peaks, or perhaps initiating a facile chemical reaction, following the electron
transfer process.
There are several other factors that make it difficult to assign the redox processes in
29b-i. The oxidation potential of the dppf ligand is somewhat solvent-dependentG. The
dppf redox couple is generally reversible; however, in the presence of water, the dppf
ligand undergoes a fast chemical reaction following oxidation47. In cyclic voltammetry
experiments run under similar conditions but employing different electrodes, the oxidation
potentials reported for dppf are +0.68 V43 (vs SCE at Pt in 0.1 M [ N B u ~ ] P F ~ / C H Z C ~ Z
at 100 mVs-') and +0.97 V42 (vs SCE at glassy carbon in 0.1 M [ N B U ~ ] P F ~ / C H ~ C ~ ~
at 100 mV s-I), which suggests that the nature of the electrode also significantly affects
the oxidation potential.

RAu-P-q&
Ph2

(29a) R = M e
(29d) R = C14H9,9-anthryl (29g) R = C S C B u - f
(29b) R = P h
(29e) R = c16H9. 1 -pyrenyl (29h) R = c6F5
(29c) R = C I O H ~1-naphthyl
,
(290 R = C e C P h
(29i) R = CH2PPh2Me
In compounds 29a-g, the quasi-reversible oxidations at cu +1.0-1.1 V occur almost
identically where dppf oxidizes at a glassy carbon electrode, which suggests that the
redox process at this potential is iron (dppf) based. The anodic waves occurring at lower
potentials in the range between +0.66 V and +0.95 V have been assigned as one-electron
oxidations of gold in 29a-g4'. Comparing the first oxidation potential of Au(PPh3)Ph
(+1.61 V) vs Au(PPh3)(4-FC&) (+2.00 V), it is expected that the pentafluorinated
phenyl substituent in 29h would push gold-based oxidation to much higher potentials,
possibly switching the lowest energy oxidation process to a dppf-based oxidation. In
cyclic voltammetry experiments on 29h, the first oxidation process (+0.98 V at a Pt
electrode) is reversible with peak-to-peak splitting of 60 mV, suggesting that this is indeed
what has occurred. Until more data are available, e.g. bulk electrolyses as a function of
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potential, it is prudent to reserve judgment about the assignment of these redox processes.
Nevertheless, what is evident is the rich electrochemistry of these complexes.

(31a) X = H
(31b) X = COOMe

(30a) X = H
(30b) X = NO2

The electrochemistry has been reported for a variety of other structural types, notably
compounds where one AuPPh3 is directly attached to a Cp ligand in ferrocene (30a,b)44,
two AuPPh3 units are bonded to the same carbon of a Cp ring stabilized by intramolecular
gold-gold interactions (31a,b)44,two AuPPh3 units are coordinated to a sulfur substituent
on a Cp ring (32) and a series of compounds where AuPPh3 is sequentially added to
cyclopentadiene (33-35)29. The reduction potentials for 30-35 occur in a fairly narrow
range (see Table 9). However, the oxidation processes vary tremendously (e.g. compare
33 vs 34) suggesting significantly different electrochemical properties that would be quite
interesting to investigate further.

Ph

Ph

+
BF4-

Finally, the electrochemistry of the organometallic gold(II1) carborane complex, 36,
has been reported45. The cyclic voltammogram of 36 in MeCN solution shows two redox
processes. The first is a reversible redox couple (-0.62 V vs SCE) that has been assigned
as a one-electron reduction to a stable gold(I1) complex. The second reduction process
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involves a quasi-reversible redox couple, presumably to the gold(1) carborane. Strong
evidence that the intermediate redox compound is a gold(I1) complex was found by
investigating the electrochemistry of an isolated gold(II) compound made by reduction of
36 with sodium amalgam. The dianionic gold(I1) compound displays an initial cathodic
process (-0.92 V vs SCE) similar to that found in the second reduction process of 36
(-0.84 V vs SCE). In addition, a reversible redox process is observed at -0.62 V vs SCE
for oxidation of the gold(1I) compound.
-I

I

Au

IX. DRUGS

Although the antibacterial effects of silver and the biological activity of gold have long
been known, few electrochemical studies have appeared on the redox properties of gold
and silver complexes of biological importance. Gold complexes such as [Au(lk)2 have
been shown to be potent cardiovascular toxins2’ while complexes such as Auranofin, 37,
have been used successfully to treat rheumatoid arthritis. While the mechanism of action
of anti-inflammatory gold drugs is not clear, the interaction of gold(1) centers with the
thiol groups of proteins and enzymes is believed to play a role.
J f

AcOH~C
S-AuPEt,

AcO
OAc

P6rez and coworkers investigated the reduction of 37 at a dropping mercury electrode48.
Figure 9 shows the electrochemical behavior of 37 i n deoxygenated alkaline 0.06 M
K 3 P 0 4 ethanovwater (1 : I ) solution using dc polarography (a) and differential pulse
polarography (b) techniques. The polarographic techniques were used to establish that the
electrochemical processes are diffusion controlled and reversible in alkaline media. Bulk
electrolysis at -0.8 V leads to an n value of 0.9 electrons per molecule and suggests
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- 0.2

- 0.4

- 0.6

V, SCE
FIGURE 9. Electrochemical behavior of Auranofin, 37, in deoxygenated alkaline 0.06 M K3PO4
ethanovwater ( I : 1) solution: (a) direct current polarography; (b) differential pulse polarography.
Reproduced by permission of the American Pharmaceutical Association from Reference 48
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FIGURE 10. The pH dependence on Ell2 of Auranofin, 37.Reproduced by permission of the American
Pharmaceutical Association from Reference 48

that the reduction involves the Au"' redox couple. Interestingly, the reduction potential is strongly sensitive to the pH values below 8.5 as shown in Figure 10. Above a
pH of 9, there is no proton-dependent pathway and the redox couple appears at -0.5 V
vs SCE (see Table 10). Below a pH of ca 8.5, a proton-dependent reduction pathway
is indicated. Protonation of triethylphosphine (equation 6, pKa = 8.69) is believed to be
responsible for the shift in potential as a function of pH. A linear relationship between the
limiting current and Auranofin concentration was also noted in the concentration range
M. Effects of adsorption processes at the electrode surface
to 5.1 x
3.63 x
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TABLE 10. Electrochemical data (V) of gold drugs
Compound

Alternative

Oxidations

Reduction Conditions

Solvent

pH

Reference

formula
-0.5

37

Auranofin

Au(41 )

A u[ L-cys teine]

+1.19

Au(42)

Au[D-penicillamine]

+ 1.14, + 1.35

~~

LI

b
b

~-~~
~

EtOWH20 > 9
H20
1.67
H20
1.67

48
49
49

~~

Polarography, SCE reference, dropping mercury workmg elecucde
b ~ y c ~ voltammetry,
ic
SCE reference, PIworking electrode

M.

appear at concentrations above 3 x
p(c2H5)3

+ H+ 6 [p(c2HS)3Hl+

(6)

The reducing properties of antiarthritic drugs such as Auranofin, 37, sodium aurothiomalate (myocrisin), 38, sodium aurothiopropanol sulfonate (allocrysin), 39, and aurothioglucose (solganol), 40, were investigated by Huck and coworkers5'. The standard redox
potentials of drugs which instantly react with the oxidant, 5,5'-dithiobis-(2-nitrobenzoic
acid), were determined by titration with potassium hexacyanoferrate(m) in a 0.1 M phosphate buffer (pH 7.0, 25"C), at a dropping mercury electrode using a SCE reference.
Unfortunately, none of the gold-containing compounds reacted very quickly with the oxidant and the standard potentials could not be measured directly even after long incubation
periods in phosphate buffer at 37 'C".
COONa

AuS-CH~

HOHzC

H
*uO
-s- HO
OH

n

n

(39)

(38)

Anderson and Sawtelle have investigated the aqueous redox processes for the electrogenerated gold(1) species, [AuC12]-, complexed by biologically relevant ligands such
as cysteine, 41, and penicillamine, 4249. They propose an aqueous reduction mechanism
that begins with [AuCb]- as iIIustrated in equations 7-9. The progress of these electron
transfer and coupled chemical reactions can be followed by cyclic voltammetry and UVvis spectroelectrochemistry. Upon formation of [AuC12]-, addition of 41 or 42 leads to
complexation and changes in the electrochemistry which allows an estimation of the oxidation potentials (see Table 10)of the Au[cysteine] and Au[penicillamine] complexes. Cyclic
voltammetry control experiments with cysteine, cystine and penicillamine indicate that the
observed electrochemical responses do not originate from these free species in solution.
[AuCLI-

F==+

+ 2 e[AuC121- + e[AuC12]+

+ 2 CI-

(7 1

6 [AuC12]-

(8)

+ 2 C1-

(9)

[AuCI~]'

Au

The mechanisms of a wide range of bactericidal agents, including silver sulfadiazine,
43, which has an extended polymeric structureS1, were examined by Ames, Ryan and
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,

0

0

II

H,N-CH- C- OH

I
CH2

I

SH

H2N-

CH-

II

C-

OH

I
Me-C- Me
I
SH

Kovacic using cyclic voltammetry measurement at either Pt or dropping mercury working
electrodes52. Unfortunately, because of the low solubility of 43 in 0.1 M KH2P04/0.1 M
NaOH solution (pH 7.0), no reduction wave was observed.
X. IMIDES AND ANlLlDES
Two series of linear silver salts of imides and anilides, formulated as [Ag(L)2]NEh
(amide = 44a-h) and [Ag(L)z]Ag (L = 44a-e), have been studied using linear
voltammetry, cyclic voltammetry and coulometry at F't and vitreous electrodes in
a ~ e t o n i t r i l e ~The
~ , ~linear
~ . voltammograms obtained for [Ag(L)2 ]Ag show two cathodic
waves and one anodic wave (see Table 11). The first cathodic wave at cu -0.2 V vs
Ag/Ag+ for [Ag(44a)2]Ag corresponds to reduction of the loosely bound silver ion
(equation 10) and the second wave at cu -1.3 V vs Ag/Ag+ corresponds to reduction
of the tightly bound silver ion (equation 11). As expected, there is only one reduction
wave at -1.35 V for [Ag(44a)2]NEh which corresponds to reduction of the tightly bound
silver ion.

[Ag(44a)2]Ag

+ e-

ca -0.2 V

[Ag(44a)21-

+ Ago

(10)

The second cathodic process in [Ag(44e)2]Ag is broad and occurs at a very low potential
(-0.5 V vs Ag/Ag+) compared to the other silver salts in this series. This anomalous
behavior was attributed to the lower stability of the silver complex and the presence of
several isomeric forms of the acyclic imide Iigand.
Both the silver salts and the mixed silver/tetraethylammoniumsalts show anodic waves
that are similar in potential and amplitude, demonstrating similar oxidation processes
in both salts. Coulometric measurements and n values show that the oxidation process
is irreversible and involves one electron. This process was assigned as a ligand-based
oxidation. In general, the complexes with cyclic imide ligands (Ma-d) oxidize at cu
+IS V vs Ag/Ag+. The oxidation potentials of the silver complexes with acyclic ligands (44e-h) are more sensitive to changes in ligand composition. The presence of two
electron-withdrawing carbonyl groups in 44e gives rise to a higher oxidation potential than
those with only one carbonyl group (44f-h). Placing an electron donating methoxy group

.
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TABLE 1 I .
Compound

Electrochemical data (V) of imides and anilidesa
Alternative formula
[Ag(succinimide-)2]NEb
[Ag(succinimide-)2 ]Ag
[ Ag(Me4 succinimide-)z]NEh
[Ag(Me4succinimide-)z ]Ag

[Ag(phthalimide-)z ]NEb
[Ag(phrhalimide-)2 ]Ag

Oxidationsb
+ I .48‘
1 .48‘
0.Od
1.56‘

+

Au(PPh3)NHCOMe
Au(PPh3 )NHCOCH2CI
Au(PPh3)NHCOPh
Au(PPh3)NHGb NOz-o
Au(PP~~)NHC~I%N@-P

-0.18‘
-0.25’

- 1.35‘
-1.3w

-1.sod

+

+isw
.O.Od
+1 .52‘
1.52‘
0.od
1-47‘
1.45‘
0.od
+1.01‘
1.04‘
0.0d
+0.4lC
-0.1’
+0.27‘
t0.65‘

+

+
+

[Ag(benzoylimide-)2 ]NE&
[Ag(benzoylimide-)2]Ag

Reductionsb

+

+1.89
1.9@
+2.27’
1.54’
1.44d

+

+
+

-0.16‘ -1.52‘
-0.26’ -1.7od
-0.17‘ -1.3oC
-0.22’ - 1.46’

..

-0.18‘

-1.38‘

-0.48’

-1.66d

-0.2oc

-0.Y

-0.3od -0.54‘
-0.27‘ -1.38‘
-0.3od -1.74d

Reference
53.54
53
53
54
53
53
54
53
53
54
53
53
54
53
53
53
53

54
- 1.77’

-1.80d
- 1.92’
- 1.65’
-1.37’
-1.43’
-1.43’
-1.51’
-1.87’

-1.76’
-1.65’
-1.84‘
-1.75’

54
29
29
29
29
29
29
29
29
29

“Electrochemical studies reported at Pt working electrode and Ag/Ag+ reference couple in MeCN.
bValues reported in Reference 29 as E I and
~ References 53 and 54 as Epc.
‘Linear rotating disc voltammetry at UJ = 600 rpm.
’cyclic voltammetry.

in the para position of the phenyl ring (44g) makes the silver complex, [Ag(44a)2]NEk,
easier to oxidize (+0.27 V vs Ag/Ag+) than the parent complex, [Ag(44f)2JAg ($0.41 V
vs Ag/Ag+). The silver complex, [Ag(44h)2]NEk, with an electron-withdrawing cyanide
substituent, is harder to oxidize (f0.41 V vs Ag/Ag+).
Finally, in the cyclic voltammetry studies of the silver salts, there are two cathodic
waves, with similar potential values as observed in the linear voltammetry studies. However, on the return sweep in the CV, there was an anodic peak at 0 V vs Ag/Ag+ which
was attributed to oxidation of electrodeposited silveS3.
A series of triphenylphosphine gold amide complexes (45-48) was studied by
Rakhimov and coworkers29. The anodic process was in general assigned to a one-electron
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oxidation of the amide or anilide ligands, followed by a series of chemical reactions that
resulted in deposition of Auo on the platinum electrode. The aniline derivatives can be
doubly and triply ‘aurated’ (46-48) by addition of two or three (AuPPh3)+ groups.
Auration does nor have a predictable effect on the oxidation potential (see Table 11).
However, changing the substituent on the phenyl ring appears to have a significant effect
on the oxidation potential. For example, [(AuPPh3)3NC6&Me-p]+ with an electrondonating methyl in the para position of the ring oxidizes at +0.95 V vs Ag/AgCl, while
the para-nitro derivative is harder to oxidize by 560 mV.

(PPh3)Au-

N

/
\

H
(PPh3)Au-

R

/

N

\

Au(PPh3)

R

Au(PPh3)

/
(PPh3)Au-

N-Au(PPh3)

\

R
(48a) R = C6H4N02-p
(48b) R = C6H4Me-p

1

The first cathodic process for the amide gold complexes is proposed to be a oneelectron reduction. As the number of (AuPPh3)+ groups increases, the reduction process
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becomes less reversiblez9. The para-nitroaniline complexes also show a second cathodic
process with n values of 2.8-4. A scheme was proposed that included initial one-electron
reduction of the p-nitroaniline ligand followed by formation of metallic gold and
regeneration of a molecule that is electrochemically active in the same potential range29.
XI. OTHER LIGANDS AND STRUCTURAL TYPES

This section includes selected examples of electrochemistry of gold and silver complexes with other ligands and structural types that were not included in previous sections.
We have also included a list of references divided into the following areas that can be
consulted for additional information: sulfur- and nitrogen-containing macro cycle^^^-^^,
p ~ r p h y r i n s ~ ' -and
~ ~ clusters97- 16.

'

A. Macrocycles
Macrocycles are well known to bind to a variety of metals in several oxidation states and
the macrocycle cavity size can be vaned to electronically tune redox couples. A number of
electrochemical investigations have been conducted on gold and silver macro cycle^^^-^^.
Electrochemical data for complexes with the sulfur-coordinated macrocycles, [9]aneS3
(49) and [18]aneS9 (SO) are listed in Table 1257,62.Silver(1) and gold(1) coordinate to
two molecules of 49 but only one molecule of 50. In [Ag(49h]+, the silver atom is six
coordinate. In contrast, the X-ray structure of [Au(SO)]+ shows a distorted tetrahedral
TABLE 12. Cyclic voltammetry data (V) of other ligands and structural types
Compound

Oxidations

Macrocycles -Suljiur
[A~(49)21+

Reductions

Conditions

Reference

a

+0.75
+0.36, +0.56

-0.57

a

+1.00

-0.42

a
a

62
57
62,66
57

[Au(S1)J3+

-0.16, -0.62, -0.98

b

70

[Au(52)I3+

- 1.28,- 1.42, - I .89

b

70

b

68

- 1.1

C

-0.59

C

80
80

IAg,3(113 - Fe(co),)sl3[Pd(A~PPh3)81~+

-0.37(rev),-0.65(rev)

b

1 07

- I .8O(rev),- 1.98(rev)
1.72(rev)

d

I10

[Pt(AuPPhj)s 12+

- 1.57(rev),-

d

111

-1.03(rev),-l.l ](rev)

d

111

+O. 12, +0.46

rAg(49)21+
IAu(SO)l+
[Ag(50)1+
Macrocycles -Nitrogen

[Ag(51)l2'

t0.86

Porphyrins

+OX,
+1.68

Ag(53)
[Au(53)1+
CIusters

+ 1.64

[Au(AuPPh3)8 J3+
~

~~

aMeCN, ws Fc/Fc+ couple
bMeCN, vs SCE
'CH2CI2. referenced to Ag/AgCl
dCH2C12, ws Fc/Fc+

but

reponed YS SCE
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geometry with Au' coordinated to four of the sulfurs in the ring62. Figure 11 shows a
cyclic voltammetry experiment on [Au(50)]+ in MeCN solution66. Two redox couples
occur at +0.36 V and +0.56 V (vs Fc/Fc+) which were assigned as two successive
one-electron oxidations: Au' + Au" followed by Au" + Au". The corresponding Ag'
macrocycle complexes, [Ag(49)2]+ and [Ag(SO)]+, show one oxidation process at higher
potentials that have been assigned as the Ag'/" couples. The influence of the macrocycle
ring size can be illustrated by comparing the oxidation potentials for the complexes with
49 and 50. The gold and silver complexes with 50 are harder to oxidize reflecting the
increased stability of Au' and Ag' coordinated to the larger macrocycle.

Examples of the electrochemistry of nitrogen-containing gold and silver macrocycles are
listed in Table 12. Kimura and coworkers have investigated a series of complexes based
on cyclams such as [14]aneN4 (51)70.Cyclic voltammetry experiments of [Au(51)l3+ in
0.1 M [Bu4N]PF6/MeCN solution at a glassy carbon working electrode shows three irreversible reduction waves. The reductions which occur at -0.16 V, -0.62 V and -0.98 V
vs SCE were assigned as successive one-electron processes. The Aum complex with the
triphenylphosphine-pendant cyclam, 52, shows dramatic shifts in the reduction potentials,
indicating that this gold complex is greatly stabilized toward reduction (see Table ~ 2 ) ~ ' .
Po and coworkers investigated the Ag" complex, [Ag(51)l2+ 68- Cyclic voltammetry
experiments at a Pt electrode in 0.1 M [Et4N]C104/MeCN solution show a quasi-reversible
redox couple at +0.86 V w SCE assigned to the Ag"/" couple.

I

+ 0.05

I
+ 1.05 V vs FC/FC*

FIGURE 11. Cyclic voltammetry experiment on [Au(SO)]+ in MeCN. Reproduced by permission of
Kluwer Academic Publishers from Reference 66
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Porphyrins
.
There is great interest in studying the electrochemistry of gold and silver porphyrins
in aqueous and nonaqueous solution^^^-^^. The redox reactions for rnetalloporphyrins
include changes in the oxidation state of the porphyrin nucleus and, in some cases,
changes in the oxidation state of the metal. The porphyrin ring tends to stabilize the
higher oxidation states of silver and gold.
The electrochemical data for many gold and silver porphyrins can be exemplified by
considering their complexes with the tetraaphenylporphyrin ring, 53 (see Table 12). The
metal-based oxidation (Ag"/m couple) of Ag(53) at +0.55 V vs SCE occurs between the
porphyrin ring oxidation (+1.64 V) and reduction (-1.1 V) processes. In contrast, in the
Auru analog, [Au(53)]+, gold is inert and only ring-based redox processes are observed.

188

Ahmed A. Mohamed. Alice E. Bruce and Mitchell R. hf. Bruce

C . Clusters
The tendency of clusters to undergo facile rearrangements or decomposition upon electron transfer, as well as the presence of a large number of redox centers, can make the
~ - ~interesting
~~.
example
assignment of the redox behavior of clusters a ~ h a l l e n g e ~ An
is provided by [Ag,3(pyFe(C0)4}gl3-, a cluster composed of a core of 12 silver atoms
arranged in a cuboctahedron structure, with an additional silver atom at the center bridging to the other 12 silver atoms (54)Io7.Eight p ~ - F e ( C 0 ) 4units cap each triangular face
of the cuboctahedron (not shown in 54). Cyclic voltammetry experiments of [Ag13(p3Fe(C0)4)gl3- at low concentrations (0.1 mM/MeCN) display two reversible cathodic
processes (see Table 12). Controlled potential bulk electrolysis at -0.5 V yields an n value
equal to one electron per cluster molecule. However, at higher concentrations (2.1 mM),
the first redox process remains reversible, but the second becomes irreversible, suggesting
a second order following reaction. Figure 12 shows the cyclic voltammogram recorded at
the higher concentration using a Pt working electrode and a scan rate of 200 mVs-'. The
large wave that appears in the cathodic scan at cu -0.2 V vs SCE appears to be a silver
surface wave, i.e. the result of oxidation of silver metal deposited at the electrode in the
reduction scan. The wave is similar in shape and potential to that seen in the analysis of
silver during a stripping voltammetry experiment"'.

- 1.0

V

- 1SO0

FIGURE 12. Cyclic voltammogram for 2.1 x
M [EbN][Agl3(p3-Fe(C0)4)8]at a platinum electrode in 0.2 M [EbN]C104/MeCN at scan rate 200 mVs-'. Reproduced by permission of Plenum Press
from Reference 107
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I

I

I

+1.0

+0.5

0.0

- 0.5

I

-1 0
Potential

-1.5
(V vs SSCE)

FIGURE 13. Cyclic voltammogram for [Pt(AuPPh,)8I2+ in 0.1 M [ B Q N ] P F ~ / C H ~ C Iat~ scan rate
200 rnVs-'. Reprinted with permission from Reference 11 1. Copyright (1989) American Chemical
Society

The electrochemistry of [Pd(AuPPh3)*l2+ was investigated by cyclic voltammetry and
differential pulse polarography in CH2C12 and MeCN solutions"'. This cluster undergoes
two stepwise, reversible one-electron transfers, thus showing an EE reduction mechanism
(see equations 12 and 13, and Figure 13). It is interesting to note the large shift to more
positive potentials as the central metal atom in [M(AuPPh3)sJn+ changes from PdU to
Pt" to Au" (see Table 12)11091'1[Pd(AuPPh3)8I2+
[Pd(AuPPh3)8]+

+ e-

+ e-

--1[Pd(AuPPh3)8]+
__1 Pd(AuPPh3)8

El12 = -1.80 V vs Fc/Fc+

(12)

V vs Fc/Fc+

(13)

E1/2 = -1.98
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